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Experiments are reported on some aspects of oestrogen toxicity in the Beagle dog and the 
non—human primate.
Ethinyl estradiol produced in the dog, toxic changes in the reproductive system, blood and skin. 
Some females showed slight focal papilliform proliferation of the genital serosa.
Ethinyl estradiol induced in rhesus monkeys biochemical changes indicating hepatic dysfunction. 
No histological changes were detected in the liver by light microscopy, but by electron microscopy 
minor ultratructural abnormalities were identified within hepatocytes. Bile flow increased when 
ethinyl estradiol was given to rhesus monkeys with an intact enterohepatic circulation. Ethinyl 
estradiol did not cause proliferative serosal lesions in female rhesus monkeys but hyperplasia of the 
fimbrial epithelium of the Fallopian tube was found.
Ethinyl estradiol had no apparent effect on lactation in rhesus monkeys, although there was 
evidence of oestrogen secrçtion through the milk. The effects of ethinyl estradiol in neonatal rhesus 
monkeys were similar to those in adults.
When given to pregnant rthesus monkeys during the period of organogenesis, ethinyl estradiol 
appeared to cause early embryonic death and abortion but no teratogenic effects were found in 
foetuses derived by caesarian section.
The combined hepatotoxicity of ethinyl estradiol and chenodeoxycholic acid in baboons was 
essentially similar to that of chenodeoxycholic acid alone.
High dose levels of diethylstilboestrol given to pregnant rhesus monkeys ve^pparen tly  
embryotoxic. Two infants were reared for 84 weeks ; the female's reproductive tract was normal, 
but the male's prostate and seminal vesicles were small.
Interpretation of oestrogen tumorigenicity to dogs depends on establishing baseline background 
data. The spontaneous incidence of mammary tumours and dyplasias in forty nulliparous 8-year old 
female Beagle dogs is described.
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P R E F A C E
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Hormone is a Greek word meaning " I stir up or stimulate” and was first used by Bayliss and 
Starling in 1902. They defined a hormone as a chemical substance produced in one part of the body 
that diffuses or is transported to another area where it influences activity and tends to integrate 
component parts of the organism. This definition remains essentially unchanged. Hormones regulate 
specific processes and therefore it must be appreciated that an excess is as detrimental as a deficiency.
As early as 460—322 B.C. the writings of Hippocrates and Aristotle contain information that 
there might be internal control over some functions of the body. Aristotle wrote that "the excision of 
sows" ovaries quenched their sexual appetite and stimulated growth". However, only twentieth 
century endocrinology has established the association of the ovary with the female sex hormones, 
oestrogens and progestogens, and it was not until the second quarter of this century that these 
humoral substances started to be identified. It is therefore, a remarkable fact that in 1974 an 
estimated 50 million women in developed and developing countries around the world were taking 
oestrogens combined with progestogens, in the form of oral contraceptive pills, (Piowtrow and 
Lee, 1974).
The early history of oestrogenic hormones has been reviewed by G.W. Corner (1964). The 
initial advance was made by three investigators working independently who found that the way to 
isolate these hormones was by lipid extraction, (Iscovesco, 1908 ; Fellner, 1912 ; Herrman, 1915). 
Following on from this discovery Allen and Doisy (1923) developed a bio—assay for oestrogens based 
on a rat vaginal smear, enabling them to measure potency in terms of a physiological unit, the 
Allen—Doisy rat unit. All substances producing oestrus and vaginal cornification in spayed rats or mice 
are therefore said to be oestrogens. The last pioneering discoveries were made by the chemists Doisy 
(1930) and Butenandt (1930) who extracted the hormone oestrone in crystalline purity following 
Aschheim's (1927) finding that large quantities are present in human urine during pregnancy.
In 1933 Schwenk and Hildebrandt reduced oestrone to oestradiol.
Oestradiol is the principal natural hormone in women and is the hormone secreted by the ovary. 
Oestrogens are also formed in the adrenal cortex and placenta. Oestradiol exists in the body in 
equilibrium with the less biologically potent oestrogen, oestrone, which in turn is converted to 
oestriol for excretion by the kidneys. Oestradiol is metabolised largely by the liver where it is 
partly oxidised to inert compounds and partly converted to oestrone and oestriol (Fig. 1 ).
Oestradiol, oestrone and oestriol are steroid molecules derived from perhydrocyclopentano— 
phenthrane nucleus. Preparations of these and other naturally occurring oestrogens, such as 
oestradiol benzoate, together with semisynthetic derivatives including ethinyl estradiol (Fig. 2) 
and mestranol are now either extracted from human or mare's urine or chemically synthesised 
for commercial use. Ethinyl estradiol was first synthesised in 1938 (Inhoffen et al) and is a 
potent orally active oestrogen. Commercially, ethinyl estradiol is prepared by the treatment of 
oestrone with potassium acetylide in liquid ammonia. Ethinyl estradiol is 19—nor—17a—pregna—1,
3, 5 (10)—trien—20—yne—3, 17j3—diol. (British Pharmacopoeia, 1977). In Western Europe alone, 


















































Synthetic oestrogens were first described by Dodds et al in 1938. While the action of these 
synthetic oestrogens appears to be identical to that of the natural compounds, they are biochemically 
quite dissimilar, being derived from stilbene. Synthetic preparations include benzestrol, 
diethylstilboestrol (Fig. 3) and hexoestrol. Diethylstilboestrol is 3, 4 —di—(4—hydroxyphenyOhex— 
3—ene (British Pharmacopoeia, 1977) and is prepared by converting anethole hydrobromide to an 
Intermediate ether using sodamide in liquid ammonia and this is converted to diethylstilboestrol by 
heating with potassium hydroxide in ethylene glycol.
A. Therapeutic usage and adverse reactions in humans
Oestrogen preparations are, or have been, used for a wide variety of therapeutic reasons in 
women, the most important of which are :
(1) Hormonal contraception
(2) Treatment of menopausal disorders and hormone replacement therapy
(3) Pregnancy diagnosis
and (4) Treatment of threatened and/or recurrent abortion
(1 ) Hormonal contraception
Although there are several different types of oral contraceptive regimens, most fall into 
two main categories : by far the most important is the combined pill, in which both oestrogen and 
progestogen are administered daily for three weeks out of four. The sequential pill contains 
oestrogens for the first 14 days of the cycle and progestogens for the following 6 days. Only two 
oestrogens ethinyl estradiol and mestranol are currently used in oral contraceptive pills but at least 
eight different types of progestogens are available. Ethinyl estradiol together with mestranol were 
included by chance in the first oral contraceptive formulations as contaminants of the first 19— 
norprogestins (norethynodrel and norethindrone). The original agents used in clinical trials 
contained either 150 or 60 pig of mestranol per tablet and these levels were adjusted to optimise 
menstrual bleeding patterns which result from cyclical activity (Helton and Goldzieher 1977). 
Originally, contraceptive properties were entirely attributed to the 19—norprogestins but 
Goldzieher et al (1975) have shown that they may act synergistically to inhibit ovulation at 
dosage rates which by themselves are insufficient for consistent ovulation inhibition.
Following the first large scale antifertility trials (Pincus, 1957 ; Pincus et al, 1958,1959), oral 
contraceptives were first approved for prescription use in the United States in 1959, and in Britain 
in 1930. Oral contraceptive piils are the "medicine" most widely taken by healthy people;
850 million of these pills are consumed in a year in Britain alone.
Their mode of action is at the level of the hypothalamic—pituitary system. Inhibition of the 
release of gonadotrophic hormones by a negative feedback mechanism prevents ovulation,
(Baird, 1976). The menstrual bleeding is caused by withdrawal of the oestrogen.
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The dosage of ethinyl estradiol varies in different formulations. In 1969 the Committee on Safey 
of Drugs, predecessor of the Committee on Safety of Medicines, recommended a maximum dosage of 
50 pig per day, although in some preparations the dosage is now as low as 30 pig (British Medical Journal, 
1976 a).
Vessey and Doll (1976) have reviewed the adverse effects of oral contraceptives. It is well 
known that oral contraceptives cause minor side effects such as nausea, headache or breast tenderness, 
which in themselves are sufficient reason for cessation of treatment. However, there are more 
serious effects particularly with respect to cardiovascular disease (Beral and Kay, 1977 ; Vessey 
et al 1977). Oral contraceptives can cause deep vein thrombosis, pulmonary embolism and certain 
types of cerebrovascular disease, especially thrombotic stroke (Royal College of General Practitioners, 
1974). There is also strong evidence that they can cause acute myocardial infarction (Hennekens and 
MacMatton, 1977), and in some women may also produce malignant hypertension (Zech et al 1975). 
Cholelithiasis is an important non—cardiovascular adverse effect (Lancet, 1973) and Bennion et al 
(1976) have reported that oral contraceptives may induce alterations in human gall bladder bile 
suggesting a biochemical basis for an increase in gall bladder disease. Similarly, cervical erosion also 
occurs more frequently in women taking oral contraceptives. An association has been suggested 
between oral contraceptives and hepatic neoplasia (British Medical Journal, 1975 ; Matiboubi and 
Schubik, 1976). An increased risk of admission to hospital for hepatitis has been reported by 
Morrison et al (1977).
The use of steroid contraceptives during the post—partum lactation period raises important 
questions about the effect on the amount and composition of milk and the risk that they may be 
transferred through the milk to the baby (Kessler and Standley, 1977).
Clear evidence has been found of impairment of fertility after discontinuation of oral 
contraceptives (Vessey et al 1976).
To date, it is worthwhile noting that no obvious association exists between oral contraceptives 
and breast cancer (Vessey et al 1975 ; British Medical Journal, 1976 a).
(2) Treatment of Menopausal Disorders and Hormone Replacement Therapy
The endocrine changes that occur after menopause involve a shift from the major 
oestrogen oestradiol of ovarian origin, to oestrone synthesised elsewhere in the body, particularly 
by the adrenal cortex. Oestrogens may also be continually produced in body fat from androgen 
precursors (McDonald and Longcope, 1971 ; Ryan, 1975).
: 7 :
Oestrogen lack after the menopause can be associated with vasomotor instability (hot flushes) 
and atrophy of the reproductive tract. These are well documented sequelae of a post—menopausal 
hormone deficiency and are responsive to low dose oestrogen therapy. Oestrogens may also be 
used prophylactically against osteoporosis and bone fractures (Lindsay et al, 1976 ; Horsman et a l,1977; 
Recker et al, 1977). The use of oestrogens for relief of menopausal disorders became popular in the 
middle 1960's, when oestrogens were also considered to help women to retain a youthful appearance.
A  leading proponent of this therapy has been a New York gynaecologist. Dr. R.A. Wilson. The number 
of women receiving oestrogens for treatment of menopausal disorders and hormone replacement 
therapy is unknown, but Zeil and Finkle (1975) note that dollar sales of oestrogens, particularly 
oestrone sulphate, quadrupled between 1962 and 1973. In the United Kingdom only a small 
percentage of post—menopausal women are receiving oestrogen replacement therapy, probably about 
6% of those between 50 and 59 (Doll, et al, 1976). However, the life expectancy for women has risen 
markedly so that today 30% of women are over 50 years of age (Dalton, 1977).
The dosage of ethinyl estradiol used for treatment of menopausal disorders varies from 0.01 
to 0.05 mg daily.
Recently published epidemiological surveys suggest an association between exogenous 
oestrogens and endometrial carcinoma (Smith et al, 1975 ; Zeil and Finkle, 1975 ; Quint, 1975 ; 
Mack et al, 1976). The results of these surveys were based on retrospective population analysis and 
so definite answers will therefore be only obtained from prospective studies with strict controls 
(Lancet, 1977). However, it is known that oestrogen stimulation, either endogenous or 
exogenous results in hyperplasia of the endometrium which in a small proportion of cases 
progresses to invasive carcinoma (Gusberg, 1967 ; 1976).
(3) Pregnancy diagnosis
Two preparations, both of which contain ethinyl estradiol combined with progestogens were formerly 
extensively used for pregnancy diagnosis ; they were given once daily for two or three consecutive 
days and induced uterine bleeding if amenorrhoea was not caused by pregnancy (Lancet, 1974a). 
Pregnancy tests performed on urine have now superseded this form of pregnancy diagnosis.
The dosage of ethinyl estradiol in these preparations is 0.05 mg and 0.01 mg per tablet respectively 
for two or three days.
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Mothers who take hormonal preparations containing oestrogens during the teratogenic period 
of pregnancy, i.e. from 34th to the 50th day from last menses, fall into two main groups. The 
first group comprises those women given hormonal pregnancy tests. The second group consists 
of those mothers who conceive while taking oral contraceptive pills, or who are already pregnant 
when they start to take them.
In establishing an epidemiological association between sex hormones and possible teratogenic 
effects it must, therefore, be first appreciated that this is not a homogenous group of mothers but 
a group who have taken widely differing hormonal preparations, some containing both oestrogens 
and progestogens, for differing periods of time and for different reasons. Whether such an 
association exists is unresolved. Possible teratogenic effects include limb reduction defects 
(Janerich et al, 1974), cardiovascular defects (Levy et al, 1973 ; Nora and Nora, 1973 ;
Heinonen et al, 1977), Di George Syndrome (Nora and Nora, 1973) and the Vacteral syndrome 
(Nora and Nora, 1973). However, it is interesting to note that Yasuda and Miller (1975) found 
no association between oral contraceptive or other sex hormones and transposition of the great 
vessels.
(4) Treatment of threatened and or recurrent abortion
Diethylstilboestrol was first introduced by Smith for the prevention and treatment of 
complications of pregnancy in 1948. In the U.S.A. from 1948 till at least 1967, threatened 
abortion in particular was likely to be treated with diethylstilboestrol, often at a high dose level. 
Surveys indicate that in the U.S.A. 10,000 to 16,000 females born between 1960 and 1970 
were exposed to diethylstilboestrol [n utero (Lancet, 1974b). In England and Wales between 
1940 to 1971, 7,500 pregnant women are likely to have been treated with diethylstilboestrol at 
various dose levels for threatened abortion (Kinlen et al. 1974).
In America, the total dosages ranged from 300 to 18,200 mg in an analysis of 170 registry 
cases (Herbst etal ,  1974).
In 1970 Herbst and Scully described 6 cases of clear cell adenocarcinoma of the vagina in 
girls between 15 and 22 years. That such a rare tumour should appear in a group of young women 
suggested a special environmental influence. Investigation of the pregnancies (Herbst et al, 1971) 
showed a highly significant association with prenatal exposure to diethylstilboestrol from the 
first trimester of pregnancy. The risk of developing vaginal adenocarcinoma seems to be low in 
the exposed population and is estimated as 4 in 1,000 (Herbst et al, 1974), although in an analysis 
of 170 registry cases, recurrences developed in 37 of the patients and 24 of them died. Only one case 
has been reported in the United Kingdom (Monaghan and Sirisena, 1978). About two—thirds of the 
tumours arise in the vagina and one—third in the cervix. In a prospective study Herbst et al (1975) 




The first legislation controlling the production of drugs was the 1906 Pure Food and Drug 
Act U.S.A. Subsequently an incident in 1937 when deaths occurred following the administration 
of sulphanilamide elixitr preparation containing an inappropriate solvent diethylene glycol promoted 
the 1938 legislation (U.S.A.), requiring new drugs to be tested for safety and Food and Drug Administ­
ration clearance before marketing. In Western Europe drug safety regulation was to follow the 
thalidomiae tragedy in 1962. In the same year further legislation was enacted in the U.S.A. requiring a 
closer control of animal and clinical testing of new compounds and from this time it was required to show 
efficacy. Contraceptive steriods were in common use prior to the enaction of the legislation of 1962.
All toxicological studies are directed towards demonstrating a dose—response relationship.
This concept is the only fundamental law of toxicology. The scope of suggested or obligatory 
testing procedures in animals varies according to the category of the substance and with the duration 
and intensity of exposure.
Rodents, Beagle dogs and non—human primates have been used as toxicological models in 
contraceptive development. The current requirements of the U.S. Food and Drug Administration for 
animal tests for contraceptives of the hormonal type, and also for progestogens and oestrogens 
for prolonged non—contraceptive use are shown in Table 1. (Owen and Briggs, 1976).
Similar requirements have been adopted by such countries as Sweden and Australia and 
other countries, notably the United Kingdom, also show great interest in whether carcinogenicity tests 
in other species apart from rodents have been conducted. The Medicines Act (1968, 1971) requires 
manufacturers to provide evidence of safety, efficacy and quality.
The conventional chronic long-term toxicity study remains a key feature in safety 
assessment. Animal studies are essentially comparative in that spontaneous and induced pathological 
manifestations are compared in control and test animals simultaneously. It is essential to 
determine whether an observation or finding is attributable to the test compound and, if so, 
whether its incidence is dose—related. Clinico—pathological findings can be categorised into 
three groups — the recognised common pathology of the species under investigation, changes 
predictable by virtue of the pharmacology of the compound, and manifestations of unusual and 
unpredicted responses.
Ideally metabolic data should be available before setting up long-term  animal toxicity 
studies. The knowledge of the metabolism of synthetic and naturally occurring oestrogens is very 
meagre. The metabolic evidence to date indicates that, apart from the great apes, there appears 
to be no ideal species. (Diczfalusy, 1972 ; Fotherby, 1974; Cskin et al 1977).
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TABLE 1
Animal toxicity studies for oestrogen and progestogen contraceptives
Clinical study Animal toxicity study 
requirements (F.D .A .)
Phase 1 (limited to a few subjects for 
up to 10 days administration).
90—day studies in rats, dogs and monkeys.
Phase II (approximately 50 subjects 
for 3 menstrual cycles).
1—year studies in rats, dogs and monkeys.
Phase III (clinical trials) 2—year studies in rats, dogs and monkeys. 
Initiation of 7—year dog and 10—year 
monkey studies prior to start of Phase III.
New Drug Application No further requirements but must include 
u p -to -d a te  progress reports on long-term  
dog and monkey studies.
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The conventional procedure for a long term study is to have one control group and at least 
three groups of dosed animals. The lowest dose rate is usually comparable on a bodyweight basis with 
the intended human therapeutic dose or a small multiple thereof. The highest dose is intended to 
establish the target organs or systems for toxic effects, providing a so-called effect level and perhaps 
thereby giving clues as to counter-measures or antidotal treatment. The intermediate dose is a 
multiple of the proposed therapeutic dose and is intended to establish safety factors. During the 
studies, the animals are subjected to regular clinical examinations and bodyweight measurements, 
with food and water intake calculated. Blood and urine are subjected to a gamut of biochemical and 
cytological examinations. At termination, post mortem examination is accompanied by organ weight 
analysis and histopathological examination.
In studies designed to evaluate the safety of oral contraceptive steroids, dosage levels of 1, 10 
and 25 times the anticipated human dosage level are used for dog studies, 1 , 10  and 50 times for 
monkey studies, and for rodents 1 , 10  and possibly 100 times are used. The use of the rat in 
carcinogenicity studies is generally accepted and a 2—year period coincides with the average life span 
(average mortality at 2 years 50%). The use of dogs and non—human primates in carcinogenicity 
studies of 7 and 10 year's duration respectively is more controversial. The life expectancy of a Beagle 
dog has been estimated as 12 years (Andersen and Rosenblatt, 1965). The life span of rhesus monkeys 
under experimental laboratory conditions is unknown.
The literature contains many accounts of the administration of oestrogens to various animal 
species. Despite the wide general use of oestrogens, there are few published toxicity studies in the 
common laboratory animals. These studies have been initiated to investigate some aspects of the 
toxicity of oestrogens in Beagle dogs and non—human primates.
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C H A P T E R  O N E
THE ORAL TO X IC ITY  OF E TH IN Y L  ESTRADIOL  
WHEN ADM INISTERED TO BEAGLE DOGS A T A 
DOSE RATE OF 1 mg/kg/day FOR 28 WEEKS
: 13 :
IN TRO DU CTIO N
There have been several published accounts of the administration of natural or synthetic 
oestrogens to dogs, and their effects on the male and female reproductive tract, blood, bone marrow, 
and skin have been well documented. One of the more interesting features of long-term  administration 
of oestrogens to dogs is their effect on the genital serosa. Mawdesley—Thomas and Sortwell (1968) 
reported that proliferative serosal changes, especially of the uterine serosa and mesometrium, occurred 
as a primary response to a novel steroidal oestrogen. O'Shea and Jabara (1971) made similar 
observations when diethylstilboestrol was administered to female dogs. In addition, they reported the 
occurrence of proliferative lesions in the epididymal serosa in male dogs. In order to find out whether 
ethinyl estradiol would induce proliferative changes of the genital serosa, the effects of long-term oral 
administration on the Beagle dog were studied.
M A TER IA LS AND METHODS
Seven pure—bred Beagle dogs(3 male and 4 female) were selected and housed singly in kennels.
An eight—week period was allowed for preliminary investigations to take place and for the animals to 
adjust to their new environment. During this period one of the female dogs was ovariectomised.
Details relating to the age and bodyweight of individual animals at the time dosing began are shown in 
Table 2.
All dogs were given a complete dry diet and water was freely available at all times. The ethinyl 
estradiol was diluted 1 to 10 with lactose and then administered in gelatine capsules once a day seven 
days a week at a dosage level of 1 mg ethinyl estradiol/kg (10 mg/kg/day of the mixture). Following 
adverse clinical findings, the experiment was terminated after 28 weeks' dosing.
Food and water consumption and any signs of ill health were monitored daily. Bodyweight was 
recorded at weekly intervals. Veterinary examinations and laboratory investigations were performed 
before the experimental period and then 4, 8, 12, 16, 20 and 26 weeks after dosing started. The 
haematological investigations comprised counts of total red and white cells, differential white cells, 
platelets and reticulocytes, and estimations of packed cell volume, haemoglobin, erythrocyte 
sedimentation rate and prothrombin index. The biochemical investigations comprised determination 
of plasma urea, plasma glucose, serum proteins (total and differential), serum alanine aminotransferase, 
serum alkaline phosphatase, serum bilirubin, sodium and potassium levels. Urine was examined 
qualitatively for specific gravity, pH, protein, reducing substances, glucose, ketones, bile pigments, 
urobilinogen and haemoglobin, and microscopically for sediment.
14
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On completion of the dosing period the animals were killed, and immediately afterwards a full 
macroscopic examination was performed during which the adrenals, gonads, heart, kidneys, liver, lungs, 
pancreas, pituitary, prostate, spleen, thymus, thyroid and uterus were removed and weighed. Samples 
of these tissues and of the aorta, sternal bone marrow, cervix, colon, duodenum, epididymis, eyes, 
gall bladder, ileum, jejunum, cervical and mesenteric lymph nodes, individual mammary glands, 
oesophagus, skeletal muscle, sciatic nerve, skin, submandibular salivary gland, stomach, trachea, tongue, 
urinary bladder, urethra, ureters, vas deferens, vagina and vulva, with any macroscopic abnormality, 
were then placed in 10% buffered formalin fixative. The tissues were routinely processed in paraffin 
wax, sectioned at 5 /im and stained with haematoxylin and eosin. Additional pieces of liver and 
kidney were placed in formol calcium, sectioned at 12 /im  and stained for fat with Oil Red 0 .
RESULTS
Mortalities
Dog 29 was killed on humane grounds after 16 weeks' dosing. Abnormal clinical signs noted 
during the three weeks before death included depression, inappetance and blood-stained faeces. With 
the exception of an absolute neutrophil leucocytosis the results of preterminal haematological and 
biochemical investigations were within the normal range, and no significant macroscopic or histological 
changes were found.
Dog 7d was also killed when found in extremis after 27 weeks' dosing. With the exception of 
absolute neutrophil leucocytosis and elevated plasma urea, preterminal haematological and biochemical 
investigations were within the normal range. At post mortem examination the prostate was found to be 
massively enlarged with frank abscess formation within the parenchyma (Fig. 5). Bacteriological culture 
revealed a mixed growth of Proteus and Pseudomonas pyocyaneus). Significant histological findings 
included both acute prostatitis and cystitis. The prostatitis was associated with marked squamous 
metaplasia of acinar and ductular epithelium.
Clinical signs
In the male dogs, with the exception of dog 56, the testes decreased in size and were soft on 
palpation. In dog 5<5 unilateral testicular and epididymal enlargement occurred. The prepuce of all 
male dogs became swollen and pendulous. In the female dogs vuival enlargement together with 
intermittent vaginal discharge occurred. The mammary glands of both male and female dogs were 
enlarged and the teats became pendulous. In addition, in dog 5d, a transitory cystic swelling was 
noted in one mammary gland. Varying degrees of alopecia were encountered in the skin of all animals 
with the exception of dog 29* The alopecia was usually bilateral, involving the lateral aspects of 
thorax, abdomen and thighs, and became extensive towards the end of the dosing period. Bodyweight, 
food intake and water consumption were not adversely affected.
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Laboratory investigations
Apart from raised erythrocyte sedimentation rates in dog 56 after 20 and 26 weeks' dosing and 
in dog 76 after 26 weeks' dosing, red blood cell parameters remained within normal limits. A marked 
neutrophil leucocytosis was evident in all dogs after 4 weeks' dosing (Table 3 and Fig. 4). No 
other significant changes in white cell values were detected. Platelet counts varied throughout treatment, 
but were considered to be within the normal range. Prothrombin times were not prolonged.
Biochemical investigations did not reveal any abnormalities with the exception of a slightly 
elevated plasma urea in dog 5d after 20 and 26 weeks' dosing, and slightly elevated SAP values for dogs 
49 and 69 after 26 weeks' dosing.
With the exception of minor changes which included traces of blood and protein in the urine of 
dogs 5d and 89, the results of urinalysis were within the normal range.
Macroscopic findings
The prostates of all male dogs were massively enlarged (Fig. 5) with frank abscess formation 
within the parenchyma. On section of the enlarged left testis of dog 5d areas of necrosis were noted 
with associated widespread adhesions between the tunicas vaginalis and albuginea. The fimbriae of the 
Fallopian tubes of dogs 69 and 89 appeared enlarged and congested (Fig. 6). No other macroscopic 
abnormalities were observed that were attributable to treatment with ethinyl estradiol.
Organ weight analysis
The results of both absolute and relative organ weight analysis have been tabulated in Tables 4a 
and 4b respectively. The most significant finding was that the prostates of the male dogs weighed 
between 177 g and 406 g. Normal prostatic weight for untreated dogs of this age is between 5 g and 
15 g. The group mean prostatic weight was 2.243% of the bodyweight. In addition a marked unilateral 
increase in testicular weight was found in dog 5<5, in which the left testis weighed 27.3 g and the right 
testis weighed 9.5 g.
: 17 :
TABLE 3
Individual and group mean absolute neutrophil leucocyte values (1,000/cmm)
Animal No./Sex
Weeks dosed
0 4 8 12 16 20 26
2f 11.1 28.5 7.4 12.6 - - -
3m 8.6 38.9 6.4 9.4 16.0 10.6 9.0
4f 5.0 32.8 11.9 12.4 13.6 10.9 6.1
5m 8.2 21.8 10.7 15.2 13.6 11.4 11.9
6f 7.6 18.1 11.1 14.1 16.0 14.4 10.6
7m 9.7 23.5 9.4 16.5 14.6 15.7 15.8
8f 3.3 19.6 10.5 22.2 17.0 12.5 7.6
Mean 7.6 26.2 9.6 14.6 15.1 12.6 10.1
Figure 4 : Group mean absolute neutrophil leucocyte values (1,000/cmm)
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Figure 5 Dog 16 
Macroscopic appearance o f massively enlarged prostate (P). 
Note also urinary bladder (U.B.)
Figure 6 Dog 69 
Macroscopic appearance of the enlarged Fallopian tubes (arrows) 
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The testes of all male dogs showed atrophy of seminiferous tubules together with inhibition of 
spermatogenesis ( Fig. 7). The epididymides of dogs 36 and 5d showed atrophy of the ductular 
epithelium. In addition, acute orchitis and marked interstitial fibrosis of the epididymis were found in 
the markedly enlarged testis of dog 5<5. Marked squamous metaplasia of the acinar and ductular 
epithelium with associated acute inflammatory cell infiltration, haemorrhage and necrosis was 
observed in the prostates of all male dogs (Fig, 8).
The morphological appearance of the ovaries of the entire female dogs (29 69 and 89), was 
consistent with the state of anoestrus. These animals also showed varying degrees of hyperplasia of the 
fimbrial epithelium of the Fallopian tubes. In all female dogs, dilatation of endometrial glands in the 
uterus and hyperplasia together with cornification of the vaginal squamous epithelium was seen 
(Fig. 9). Slight focal papilliform proliferation of the uterine mésothélium was noted in dog 49 
(Fig. 10—11 ) and of the Fallopian mésothélium in dogs 69 and 89.
In all male dogs, both gynaecomastia, characterised by hyperplasia of ducts and acini of mammary 
glands, and simple and papilliform cyst formation (Fig. 12) were evident. The majority of mammary 
glands in all treated female animals showed ductal hyperplasia with, in two dogs, simple and papilliform 
cyst formation ; acini, however, were small and inactive. Focal areas of squamous metaplasia of the 
thyroid acinar epithelium were present in dogs 5d, 69, 76 and 89. Atrophy of the hair follicles and 
sebaceous glands was noted in the skin of all clinically affected animals. The morphology of the 
adrenals, pituitary and sternal bone marrow was considered to be within the normal range for dogs of 
this age group.
DISCUSSION
These results show that ethinyl estradiol at a dosage level of 1 mg/kg/day induces focal 
papilliform proliferation of the genital serosa in female dogs. This finding confirms previous 
observations made by Mawdesley—Thomas and Sortwell (1968) and O'Shea and Jabara (1971) that 
proliferative serosal changes may occur as a primary response to certain oestrogens in dogs. The 
pathogenesis of these proliferative lesions is obscure but they may be associated with the role 
oestrogens play in body defense. Oestrogens, either natural or synthetic, have been shown to be the 
strongest stimulant of the reticulo—endothelial system (Nicol and Ware, 1960 ; Nicol et al, 1961 ;
Nicol et al, 1964) and tissue macrophages are widely distributed in the peritoneal mésothélium (Furth 
et al 1972). It is possible that such lesions may be due to oestrogenic stimulation of fixed macrophages 
within the genital serosa.
Jabara (1959 ; 1962a) and O'Shea and Jabara (1971), working with diethylstilboestrol, reported 
papillary proliferation of the ovarian mésothélium. Local invasion, and the presence of lesions 
considered to be métastasés on non—genital serous membranes, suggested that these changes were 
attributable to malignant ovarian tumours. Hormone withdrawal (Jabara 1962a) led to regression of 
ovarian tumours with fibrosis and calcification of secondary growths, indicating that these tumours are 
hormone—dependant. . 2 2
Figure 7 Dog 16 
Transverse section of testis showing diffuse inhib ition o f 
spermatogenesis w ith in  seminiferous tubules. Haematoxylin and eosin (x50).
a
Figure 8 Dog 16 
Transverse section of prostate showing squamous metaplasia (sm) 
of acinar epithelium. Note also prostatic stroma (st). Haematoxylin and eosin (x125).
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Figure 9 Dog 69
Transverse section of the vagina showing hyperplasia and cornification 
of the squamous epithelium (-^). Haematoxylin and eosin (x125).
Figure lODog 49
Transverse section of uterine horn showing papilliform proliferation 
of the mésothélium ( -*-). Note also myometrium (m). 
Haematoxylin and eosin (x 160).
; 24 :
1Figure 11 Dog 49
Transverse section of uterine horn showing papilliform proliferation 
of the mésothélium ( ■*-). Note also myometrium (m). 
Haematoxylin and eosin (x200).
Figure 12 Dog 56
Transverse section of mammary gland showing papilliform cyst formation 
Haematoxylin and eosin (x50).
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In this experiment the ovarian mésothélium was unaffected by the administration of ethinyl 
estradiol. The proliferative lesions affecting the genital serosa were substantially less than those 
previously recorded, however, direct comparison is not possible due to differing dose rates and routes 
of administration. Nielson et al (1976) have classified such lesions as "hormone dependent tumour 
like lesions".
In the female dogs, vulval enlargement, hyperplasia and cornification of the squamous vaginal 
epithelium, dilatation of the endometrial glands (Sokolowski et al 1973), hyperplasia of the fimbrial 
epithelium ofi the Fallopian tubes (Verhage et al 1973) and ductular hyperplasia of the mammary gland 
(Nelson and Kelly 1973) appear to be related to the normal physiological manifestations of endogenous 
oestrogens.
Other changes were encountered involving the testis, epididymus, prostate, skin and blood and 
these were essentially similar to those recorded in previous studies with oestrogens. Table 
5 summarizes these physiological and toxicological manifestations of various oestrogens to dogs and 
compares them with the findings in this study.
ABSTRACT
Ethinyl estradiol was administered orally to a group of seven Beagle dogs at a level of 
1 mg/kg/day. Two dogs died during the dosing period and the experiment was terminated after 28 
weeks dosing.
Toxic changes were noted in the male and female reproductive system, blood and skin. 




Summary of administration of oestrogens to dogs by previous authors
Tissue Investigator Oestrogen Effect
Testis Mulligan (1944)







Schwartz et al (1969) Quinestrol
Wadsworth Ethinyl estradiol
Inhibition of spermatogenesis 
and atrophy of seminiferous 
tubules.
Inhibition of spermatogenesis 
and atrophy of seminiferous 
tubules.
Inhibition of spermatogenesis 




Inhibition of spermatogenesis 










Atrophy of ductular epithelium.
Interstitial oedema.
Stromal fibrosis and duct 
atrophy.
Atrophy of ductular epithelium. 
Stromal fibrosis.











Schwartz et al (1969) Quinestrol
Arrest of secretion, epithelial 
hyperplasia, epithelial meta­





metaplasia and abscess 
formation.
Squamous epithelial 
metaplasia, atrophy of ducts 
and acini and abscess 
formation.
Squamous metaplasia.
Gross hypertrophy, abscess 
formation, stromal fibrosis, 
acinar and muscle wall necrosis 









Wadsworth Ethinyl estradiol Squamous metaplasia of acinar 
and ductular epithelium. Abscess 
formation.
Uterus Kunde et al (1930) Estrin











Schwartz at al (1969) Quinestrol
Ethinyl estradiol
Hyperplasia of the endometrial 
glands.
Dilatation of endometrial glands 
and oedema of the endometrial 
stroma.
Hyperplasia of the myometrium.
Oedema of the endometrial 
stroma.
Cystic hyperplasia, oedema of 
the endometrial stroma, 
endometrial atrophy, necrosis 
and pyometria.
Endometrial hyperplasia and 
myométrial hypertrophy.
Cystic dilatation of endometrial 
glands.




Mulligan & Becker 
(1947)
Jabara (1959) 









Hyperplasia of the teats
Hyperplasia of the ducts and 
increase in periductular 
connective tissue.
Proliferation of ducts and acini.
Hyperplasia of ducts and acini.
Cystic lobular hyperplasia.
Hyperplasia of the glandular 
tissue.
Gynaecomastia. Ductal 








Mulligan et al (1943) Estrone
Mulligan (1947) Diethylstilboestrol
Schwartz et al (1969) Quinestrol
Capel—Edwards et al Ethinyl estradiol
(1971)
O'Shea & Jabara (1971) Diethylstilboestrol 
Wadsworth Ethinyl estradiol
Effect
Hyperplasia of the stratified 
squamous epithelium, oedema 
of the lamina propria.
Hyperplasia of the stratified 
squamous epithelium.
Thickened stratified squamous 
epithelium, oedema of the 




Hyperplasia and cornification of 
the squamous epithelium.
Skin Gardner & de Vita Estradiol benzoate
(1940)







Schwartz et al (1969) Quinestrol
Ethinyl estradiol
Failure of hair regrowth.
Atrophy of hair follicle 
epithelium, atrophy of 
sebaceous glands.
Atrophy of epidermis, hair 
follicles and sebaceous glands; 
fibrosis of the dermis.
Atrophy of skin and hair 
follicles.
Thinning of the dermis, 
degeneration of hair follicles 
and oedema of the propria.





Tyslowitz & Dingemanse Estrone, estradiol
(1941) benzoate and
diethylstilboestrol







haemorrhage ; leucocytosis, 
followed by leucopoenia ; 
anaemia ; hyperplasia followed 














Dougherty et al (1943) Estrone and estradiol
benzoate
Schwartz et al (1969) Quinestrol









Neutrophilia followed by 
neutropoenia ; anaemia.
Leucocytosis followed by 
neutropoenia and 
agranulocytosis ; normocytic 
anaemia ; hyperplasia of the 
bone marrow.
Leucocytosis.
Neutrophil leucocytosis ; 
thrombocytopoenia and 
haemorrhagic diathesis ; 
myeloid hyperplasia.
Thrombocytopoenia ; 
leucocytosis followed by 




C H A P T E R  TW O
THE ORAL T O X IC IT Y  OF E TH IN YL ESTRADIOL WHEN A D M IN ISTER ED  TO 
RHESUS MONKEYS AT A DOSE RATE OF 500 jug/kg/week 
FOR 26 WEEKS
31 :
IN TRO DU CTIO N
With the exception of the work of McClure and Graham (1973), there appears to be little recent 
information on the safety of oestrogens when administered to non—human primate species. McClure 
and Graham reported the occurrence of uterine mesotheliomas in 7 out of 10 squirrel monkeys (Saimiri 
sciurea) given high dosage levels of diethylstilboestrol by implantation. Extreme lesions were found 
in animals killed after 11 and 14 months of administration. In one animal, lesions were observed after 
only 5 months of treatment. After prolonged administration 2 animals developed extragenital serosal 
lesions involving the adrenals, spleen and mesentery. Graham (1978) noted similar lesions in the 
squirrel monkey following the administration of oestradiol benzoate.
In view of the these observations, a preliminary toxicological evaluation of ethinyl estradiol was 
undertaken in the rhesus monkey (Macacca mulatta).
M A TER IA LS AND METHODS
Seven wild caught rhesus monkeys, 2 males, 2 entire females and 3 ovariectomised females, were 
housed separately in metal cages. A two—week period was allowed for preliminary investigations to 
take place and for the animals to adjust to their new environment. Details relating to individual animals 
and their bodyweight at the beginning of the dosing period are shown in Table 6.
All monkeys were fed a complete dry diet, supplemented by fresh fruit every second day and 
wholemeal bread each weekday. Water was freely available at all times. The ethinyl estradiol was 
dissolved in a solution of 2,5% ethyl alcohol in water,to give a concentration of 500 /ig in 0.5 ml 
(0,0125% weight/volume). The solution was administered by gavage once per week at a dose level of 
500 ^ig/kg. Monkey 4229 was dosed for 13 weeks and monkeys 625d, 6269 and 4239 were dosed for 
26 weeks before being killed. Monkeys 627d, 6289 and 4219 were dosed for 26 weeks and retained for 
a recovery period of 12 weeks before being killed.
Food and water consumption, together with signs of ill health were monitored daily, Bodyweight 
was recorded twice weekly. Veterinary examinations and laboratory investigations were performed 
before dosing started, after 4, 8, 12, 16, 20 and 26 weeks' dosing, and after 4, 8 and 12 weeks' recovery. 
The haematological investigations comprised total red and white cell counts, differential white cell 
counts, platelet counts, reticulocyte counts, packed cell volume, haemoglobin, erythrocyte sedimentation 
rate, and prothrombin index. The biochemical investigations comprised measurement of plasma urea, 
plasma glucose, serum proteins (total and differential) serum alkaline phosphatase, serum alanine 
aminotransferase (SAIT), serum leucine aminopepiidase (LAP), serum bilirubin,sodium and potassium 
Urine was examined qualitatively for specific gravity, pH, protein, total reducing substances, glucose, 
ketones, bile pigments, urobilinogen and blood pigments and microscopically for sediment.
: 32 :
TA B LES
Data relating to individual monkeys at the start of the dosing period










On completion of the dosing period, the animals were killed and immediately afterwards a full 
macroscopic examination performed, during which the adrenals, brain, gonads, heart, kidneys, liver, 
lungs, pancreas, pituitary, prostate, spleen, thymus, thyroids and uterus were removed and weighed. 
Small portions of these tissues, together with aorta, sternal bone marrow, cervix, caecum, colon, 
duodenum, epididymis. Fallopian tubes,eyes, gall bladder, ileum, jejunum, cervical and mesenteric 
lymph nodes, mammary glands, oesophagus, skeletal muscle, sciatic nerve, skin, submandibular salivary 
gland, seminal vesicles, stomach, trachea, tongue, urinary bladder, vagina and vulva, together with any 
macroscopic abnormality, were placed in 10% buffered formalin fixative. The tissues were routinely 
processed in paraffin wax, sectioned at 5 /im and stained with haematoxylin and eosin. Additional 
pieces of liver and kidney were placed in formol calcium, sectioned at 12 /im and stained for fat with 
Oil Red 0 .
RESULTS 
Clinical signs
Development of the sex skin was seen in all animals from the second week of dosing onwards. 
When dosing was discontinued, this change gradually regressed, although extensive skin folding, was 
still apparent at the end of the recovery period, especially in the males. In the male animals there was 
a slight reduction in testicular size. Menstruation was suppressed in the entire females throughout the 
dosing period. During the recovery period, both the entire and ovariectomised females showed 
oestrogen withdrawal bleeding 19 days after the administration of the last dose of the test compound. 
This bleeding persisted in both animals for four days. During week 10 of the recovery period, the 
entire female had a menstrual flow of 3 days duration and 24 days later a further menstrual bleed was 
noted. No clinically detectable mammary development occurred in any male or female animals. 
Bodyweight, food intake and water consumption were not adversely affected.
Laboratory investigations
No significant changes were detected in the haematological parameters monitored.
The results of the SAIT values and LAP values are presented in Table 7 and the SAIT values 
are depicted graphically in Figure 13. These show a rise in enzyme levels which returned to baseline 
values during the recovery period. The other biochemical investigations were within the normal range.
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After 26 weeks' dosing, both the entire and ovariectomised female monkeys (6269 and 4239) 
showed bilateral enlargement and congestion of the Fallopian tubes adjacent to the ovary and 
extending along the dorsal aspect of the broad ligament (Fig, 14 ). This change was not present in the 
ovariectomised monkey killed after 13 weeks, nor in the two female monkeys maintained for the 
recovery period. There were no other macroscopic abnormalities that could be related to treatment.
Organ weight analysis
The results of both relative and absolute organ weight analysis were considered to be within the 
normal range.
Histological findings
Histological examination of the Fallopian tubes of monkeys 6269 and 4239 revealed bilateral 
hyperplasia of the fimbrial epithelium, together with congestion and oedema in the underlying lamina 
propria (Fig. 15). In addition, in these animals there was marked kératinisation and hyperplasia 
of the squamous vaginal and vulval epithelium. Slight ductal hyperplasia of the mammary gland was 
found in the male animals sacrificed after 26 weeks dosing. Histological examination of the livers 
showed no abnormalities that could be attributable to treatment with ethinyl estradiol.
DISCUSSION
In this study with the rhesus monkey, proliferative changes involving the peritoneal mésothélium 
were not induced. A number of other workers (Engle et al, 1943 ; Scott and Wharton, 1955 ; 
Geschickter and Hartman, 1959) have also given high levels of both steroidal and non-steroidal 
oestrogens for prolonged periods to rhesus monkeys without inducing this effect. The response of the 
squirrel monkey to oestrogens appears to differ from that of the rhesus monkey. This is probably a 
reflection of innate species variation and the relatively short duration of dosing in relationship to the 
relatively long life span of the rhesus monkey. Catchpole and van Wagenen (1975) and Hodgen et al 
(1977) record that menopause occurs approximately in the 25th year of life in the rhesus monkey.
The hyperplasia of the fimbrial epithelium of the Fallopian tubes seems to disappear with cessation 
of exposure to ethinyl estradiol, indicating this change to be hormone dependent. This change has also 
been recorded by Graham 1976.
37
uFigure 14 Rhesus monkey 6269 
Macroscopic appearance of the ovary (o) Fallopian tube (t) and uterus (u). 
Arrow ( -4-  ) indicates area of congestion and hyperplasia of the fimbraroîae.
IS&Ml
Figure 15 Rhesus monkey 6269 
Transverse section of the Fallopian tube showing hyperplasia 
of the fimbrial epithelium { ).
Haematoxylin and eosin (x160).
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The increase in the liver enzyme values SAIT and LAP without definite pathological change 
indicates a functional disturbance in this organ. The results might be at variance with those of 
Goldzieher and Kraemer (1972) who stated that liver function tests did not alter when ethinyl 
estradiol was administered to rhesus monkeys for 36 months at dosage rates of 0.002, 0.01 and 
0.05 mg/kg/day in a cycle of 21 days on, 7 days off.
The effects of oestrogen administration upon the sex skin, (Bachman et al, 1935 ; 
Zuckerman et al, 1938 ; Hisaw and Hisaw 1966), the vagina (Hisaw and Hisaw 1961 ) and the 
mammary gland (Gardner and van Wagenen, 1938; Folley et al, 1939) of rhesus monkeys have 
been documented. Oestrogen withdrawal bleeding has been used to compare the relative potency 
of natural and synthetic oestrogens (Eckstein et al, 1952 ; Eckstein et al, 1967 ; Hisaw et al, 1971 
Schane et al, 1972).
ABSTRACT
Ethinyl estradiol was administered orally to a group of 7 rhesus monkeys at a dosage rate of 
500 jug/kg/week for 26 weeks.
Biochemical investigations indicated a degree of hepatic dysfunction but histologically no 
morphological abnormalities were detected in the liver.
The only significant pathological change was hyperplasia of thefimbrial epithelium of the 
Fallopian tube which was hormone dependent.
: 39 :
C H A P T E R  T H R E E
THE O R A L T O X IC IT Y  OF E TH IN Y L  ESTRADIOL WHEN A DM INISTER ED  




The experiment previously reported showed that when ethinyl estradiol was administered 
orally to rhesus monkeys at a dose rate of 500 jug/kg/week liver enzyme values were raised but no 
changes in hepatocyte morphology were detected by light microscopy. The purpose of this 
experiment was to investigate further the effect of ethinyl estradiol on hepatocyte morphology by 
both light microscopy and electron microscopy.
M A TER IA LS AND METHODS
Six wild—caught adolescent female rhesus monkeys (Macaca mulatta) were selected and housed 
separately in metal cages. Two of these animals were maintained as undosed controls. A two—week 
period was allowed for preliminary investigations to take place and for the animals to adjust to their 
new environment. The bodyweight of individual animals at the time dosing commenced are shown in 
Table 8 .
All monkeys were fed a complete dry diet, supplemented by fresh fruit every second day and 
wholemeal bread each weekday. Water was freely available at all times. The ethinyl estradiol was 
dissolved in a solution of 5.0% ethyl alcohol in water, to form a concentration of 0.0025 gm%. The 
ethinyl estradiol was administered by gavage once daily at a dose level of 1 0 0 jug/kg for 26 weeks.
Food consumption, together with clinical observations for signs of ill health, were monitored 
daily. Bodyweight was recorded at weekly intervals. Veterinary examinations were carried out 
before dosing started and after 24 weeks dosing. Laboratory investigations were performed before 
dosing commenced and then after 6 , 12 and 24 weeks dosing. The haematological investigations 
comprised total red and white cell counts, differential white cell counts, platelet counts, reticulocyte 
counts, packed cell volume, haemoglobin, erythrocyte sedimentation rates and prothrombin time.
The biochemical investigations comprised plasma urea, plasma glucose, serum protein (total and 
differential), serum alkaline phosphatase, serum alanine aminotransferase, serum leucine amino— 
peptidase, serum bilirubin, sodium and potassium.
On completion of the dosing period, the animals were killed and immediately afterwards a full 
macroscopic examination performed, during which the adrenals, brain, gonads, heart, kidneys, liver, 
lungs, pancreas, pituitary, spleen, thymus, thyroids and uterus were removed and weighed. Small 
portions of these tissues, together with aorta, sternal bone marrow, cervix, caecum, colon, duodenum. 
Fallopian tubes, eyes gall bladder, ileum, jejunum, cervical and mesenteric lymph nodes, mammary 
glands, oesophagus, skeletal muscle, sciatic nerve, skin, submandibular salivary gland, stomach, trachea, 
tongue, urinary bladder, vagina and vulva, and any macroscopic abnormality, were placed in 1 0 % 
buffered formalin fixative. The tissues were routinely processed in paraffin wax, sectioned at 5 /nm 
and stained with haematoxylin and eosin. Additional pieces of liver and kidney were placed in formol 
calcium, sectioned at 12 /im and stained for fat with Oil Red 0 .
: 41 ;
T A B LE S  '
Data relating to individual monkeys at commencement of dosing
Dosage Group Animal No./Sex Bodyweight (kg)
Undosed Control 5259 3.35
5269 4.15





Liver samples were fixed in 4% glutaraldehyde buffered with 0.05M cacodylate to pH 7.3 at 
4°C . Three 1 mm^ blocks of tissue from each animal were post—fixed in 1% osmium tetroxide 
buffered with 0.05M cacodylate to pH 7.3, dehydrated in alcohol and embedded in epoxy resin. 1 pm 
survey sections were cut and stained with 1% toluidine blue for examination with the light microscope. 
Silver/gold ultra—thin sections of representative areas were mounted on copper grids and subsequently 
stained with lead citrate and uranyl acetate. These sections were examined using a Philips EM 300 
electron microscope operating at 60 kV. Selected areas were photographed on Kodak Fine Grain 
Positive 35 mm film and enlarged as necessary.
RESULTS  
Clinical signs
Development of the sex skin together with vulval enlargement was seen in all treated animals from 
the second week of dosing onwards. In particular, the folding of the sex skin was progressive and 
towards the end of the dosing period it became extensive. There was suppression of menstruation in 
dosed animals whereas in the undosed controls menstruation, although not following a regular pattern, 
was readily observed. No mammary development could be detected in treated animals. Bodyweight 
and food consumption were not adversely affected.
Laboratory investigations
No significant changes were detected in the haematological parameters monitored.
Biochemical investigations showed that in animals receiving the ethinyl estradiol, the serum 
alanine aminotransferase values and the serum leucine aminopeptidase values were elevated during 
the dosing period. The results have been tabulated in Tables 9 and 10 . In addition in monkeys 
5289 and 5299 a slight decrease in the percentage serum albumin and a slight increase in percentage 
serum ]3 globulins.was found after 26 weeks dosing.
Macroscopic findings
The ovaries of the treated monkeys appeared small and inactive, whereas in the two control 
animals ovaries were enlarged and either mature Graafian follicles or corpora lutea were obvious 
indicating cyclical activity. The treated animals showed bilateral enlargement and congestion of the 
fimbriae of the Fallopian tubes which in the absence of ovarian activity in these animals was 
considered to be a physiological manifestation of the oestrogen administration. However, the degree 








0 6 12 24
1 Q 26 50 30 24
2 100 30 110 100 74
TABLE 10 




0 6 12 24
1 0 119 182 238 179
2 100 288 524 551 500
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Organ weight analysis
The results of the relative and absolute organ weight analyses were considered to be within the 
normal range.
Histological findings
The morphological appearance of the livers of treated animals was essentially similar to that 
encountered in the control group. In the ovaries of the treated animals only small secondary follicles 
were apparent, whereas both corpora lutea and mature Graafian follicles were evident in the control 
monkeys. The fimbrial epithelium of the Fallopian tubes in treated monkeys showed bilateral 
hyperplasia. In the uteri of treated animals, slight dilatation of occasional endometrial glands was 
evident (Fig. 16). In the cervix occasional small focal areas of squamous epithelium were 
observed, whereas in the control animals only a columnar epithelium was noted (Fig. 17). The vaginal 
epithelium of treated animals was several cells thick and heavily cornified.
Ultrastructural findings ;
In the livers of two of the treated animals, occasional hepatocytes were seen to contain 
needle-shaped electron—lucent areas which were sometimes membrane—bound (Fig. 18). In addition, 
in one of these affected animals, occasional, mainly periportal hepatocytes showed intracisternal 
sequestration of the.rough endoplasmic reticulum (Fig. 19).
No morphological abnormalities were detected in the livers of the other two treated animals, 
nor in the two controls.
DISCUSSION
The results confirm the previous observations that ethinyl estradiol may induce hepatic 
dysfunction in the rhesus monkey. Clinically, the SAIT and LAP values were found to be elevated 
throughout the dosing period. Although pathological changes were not encountered in the livers of 
treated animals with the light microscope, ultrastructural abnormalities were detected by means of 
transmission electron microscopy. However, the changes found in the hepatocytes were not 
considered to be sufficient to account for the increased SA IT  and LAP values. The needle-shaped 
electron—lucent areas seen in the cytoplasm of occasional hepatocytes in two of the four treated 
animals could possibly represent a cleft remaining after a crystal had been lysed out during 
processing. Crystalline mitochondrial inclusions have been recorded in women on steroid therapy 
(Martinez—Manautou et al, 1970). While no definite evidence exists that crystals were present in this 
study, or that they were mitochondrial in origin, these cytoplasmic clefts were not apparent in the 
control animals and were considered to be related to the administration of the ethinyl estradiol
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Figure 16
Transverse section of uterus showing cystic dilatation of endometrial glands (g). 
Note also endometrial stroma (s) and myometrium (m). 
Haematoxylin and eosin (x50).
f .
Figure 17
Transverse section of cervix showing focal areas of squamous epithelium (s). 





Hepatocyte containing cytoplasmic 'clefts' ('*-) adjacent to smooth 
endoplasmic reticulum and microbodies 
Note also m itochondria (m), glycogen (g) and smooth 
endoplasmic reticulum (s) x 22,000.
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rFigure 19
Hepatocyte showing intracisternal sequestration of granular 
endoplasmic reticulum ( ).
Note also nucleus (n), m itochondria (m) and glycogen granules (g) x 22,000.
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Ghidoni (1967) also noted these cleft—like spaces in irradiated monkey hepatocytes, but was 
uncertain whether they were significant or whether some material had been lost during processing,
Intracisternal sequestration was noted in one of the four treated animals. The term 
intracisternal sequestration is used to describe a pattern of organisation of the rough endoplasmic 
reticulum where vesicular profiles of the rough endoplasmic reticulum are seen lying within dilated 
cisternae. It is thought that the primary stage of this process is the formation of papillary processes 
from the wall of a dilated cistern. Later such processes may be pinched off to form vesicular 
structures which come to lie free within the cisternae. The formation of papillary projections from  
ductal and surface epithelial has been linked with proliferative processes, and it could be that the 
above phenomenon noted in this study is a similar process and that it reflects a type of hypertrophy of 
the rough endoplasmic reticulum. This probably represents an increase in metabolic activity 
attributable to the administration of ethinyl estradiol.
The changes observed in the sex skin, ovaries. Fallopian tubesand vagina were essentially similar 
to those recorded in the previous study. Additional changes were noted in the uterus and cervix.
In the uterus, cystic dilatation of endometrial glands following oestrogen administration has been 
recorded by Engle et al (1943), Iglesias and Lipschutz (1947), Geschickter and Hartman (1959) and 
McClure and Graham (1973).
In the cervix, Overholser and Allen (1933 ; 1935) first recorded squamous metaplasia 
following oestrogen administration. Many investigators (Engle and Smith 1935; Hisaw and Lendrum 
1936 ; Zuckerman 1937 ; Engle et al 1943 ; Geschickter and Hartman 1959) made similar 
observations. Recent studies (Graham, 1970) have shown that this spread of stratified squamous 
epithelium throughout the endocervical canal is the result of stimulation of small foci of squamous 
cells occurring naturally at this site, thus questioning the theory that the squamous epithelium arose 
by metaplasia of columnar cells.
ABSTRACT
Ethinyl estradiol was administered orally to a group of 4 rhesus monkeys at a dose rate of 100 
/ig/kg/day for 26 weeks. Two other animals were maintained as undosed controls.
Biochemical investigations indicated a degree of hepatic dysfunction. Light microscopy showed 
no significant morphological changes in the livers. By electron microscopy occasional hepatocytes 
could be identified containing needle-shaped electron—lucent areas in two out of four treated animals 
only, one of which had periportal hepatocytes with intracisternal sequestration of the rough 
endoplasmic reticulum.
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C H A P T E R  F O U R
THE EFFECTS OF E TH IN Y L  ESTRADIOL, A D M IN ISTER ED  O R A LLY  
A T A DOSE RATE OF 100 jug/kg/day FOR 13 WEEKS,
ON B IL IA R Y  SECRETION AND COMPOSITION IN RHESUS MONKEYS  
W ITH AN IN TA C T ENTEROHEPATIC C IR CU LA TIO N.
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INTRO DUCTIO N
The use of non—human primates in the experimental study of the effects of oestrogens on bile 
composition and kinetics has only recently been described. The effects of the administration of 
single doses of oestriol (Lynn et al, 1973a ; Lynn, et al, 1973b) and of seven daily doses of oestrone 
(Lynn and Williams, 1975) to rhesus monkeys with an intact enterohepatic circulation have been 
reported. Other research workers (Javitt, et al, 1975a ; Javitt et al, 1975b ; Morrissey et al,
1977) have recorded the long-term effects of subcutaneous implants of ethinyl estradiol on bile acids 
using '^^C—24 isotopes and bile cholesterol in baboons previously subjected to cholecystopexy. The 
purpose of this study was to investigate further the effects of ethinyl estradiol on bile flow and bile 
composition in rhesus monkeys with an intact enterohepatic circulation at a dose rate previously 
shown to induce changes in liver enzyme values.
M A TER IA LS AND METHODS
Three wild—caught mature female rhesus monkeys (Macaca mulatta) were allocated to the study 
(Table 11 ). They were fed a complete dry diet supplemented by fresh fruit every ' day and 
wholemeal bread each weekday. Water was freely available at all times.
The extrahepatic biliary circuit was surgically exteriorised to permit representative bile 
sampling with an electronic stream splitter. (Dowling et al., 1968 ; Campbell et al., 1971). 
Representative bile samples were taken on a 5% daily basis, i.e.one drop in twenty, and the 
remaining bile returned to the gastric antrum to maintain a virtually intact enterohepatic circulation 
(Fig. 20).
Throughout the study the animals were restrained in a chair to permit maximum freedom for 
the monkey, but to prevent interference with the biliary and gastric catheters (Fig. 21).
The animals were maintained for a three to four week period during which standard post­
operative procedures were followed, and predose investigations were carried out. Once the animal 
was stabilised, ethinyl estradiol was administered at a dose level of 100 jug/kg/day for 13 weeks by 
intragastric intubation.
The volume of bile secreted during 24—hour periods was calculated from the volume of the 5% 
sample and, from this, the individual and group mean daily bile volumes per seven—day period were 
estimated. The pH and the viscosity of the bile samples were measured daily. The bile samples 
were analysed for total bile salt concentration, phospholipid concentration and cholesterol 
concentration. From these values the group mean daily secretion rates of bile salts, cholesterol and 
phospholipids, the group mean daily molar ratios of cholesterol, phospholipid and bile salts and the 
group mean daily cholesterol saturation index per seven—day period were calculated.
: 51 :
TABLE 11 







B 4.50 29 96
D 4.55 26 94
E 4.20 25 94
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MODEL FOR CONTROLLED INTERRUPTION OF E.H.C.
LI VE R
- D R O P P E R
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FIGURE 20 Schematic drawing o f experimental model. When used as a sampling technique, every 
twentieth drop of bile was diverted, by means of the movable funnels (the black block) o f the stream 
splitter, to a sampling tube. The remainder of the bile passed into a small cup, balanced in such a way 
that only a few drops o f bile would close the switch and pump the bile back to the antral region of the 
stomach. (Campbell et al, 1971).
Figure 21 Photograph of the restraining chair, the sampling tubes 
and electronic stream splitter.
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Haematological and biochemical investigations were carried out at weekly intervals. The 
haematological investigations comprised counts of total red and white cells and platelets and 
estimation of haemoglobin concentration and packed cell volume. The biochemical investigations 
comprised determination of serum alanine aminotransferase,serum aspartate aminotransferase, 
serum alkaline phosphatase, and serum leucine aminopeptidase levels, together with estimations 
of the serum bilirubin concentration.
On completion of the dosing period the animals were killed and immediately afterwards a 
full macroscopic post mortem examination performed, during which the adrenals, brain, gonads, heart, 
kidneys, lungs, liver, pancreas, pituitary, spleen, thymus, thyroids and uterus were removed and 
weighed. Small portions or the whole of these tissues, together with samples of aorta, sternal bone 
marrow, cervix, caecum, colon, duodenum. Fallopian tubes, eyes, ileum, jejunum, cervical and 
mesenteric lymph nodes, mammary glands, oesophagus, skeletal muscle, sciatic nerve, skin, salivary 
gland, stomach, trachea, tongue, urinary bladder, vagina and vulva, together with any macroscopic 
abnormality were placed in 10% buffered formalin fixative. The tissues were routinely processed in 
paraffin wax, sectioned at 5 and stained with haematoxylin and eosin. Additional pieces of liver 
and kidneys were placed in formol calcium, sectioned at 12 /im and stained for fat with Oil Red 0 .
RESULTS
Clinical observations
The administration of ethinyl estradiol produced clear changes in secondary sexual 
characteristics of all three monkeys with the result that at the end of the dosage period, the sex skin 
extended from the perineum along the abdomen and the thighs. With the exception of slight loss of 
bodyweight, particularly during the post—operative predose period, all three monkeys remained in good 
condition.
Laboratory investigations
The administration of ethinyl estradiol produced a marked increase in the individual and group 
mean daily bile volume. (Table 12 and Fig, 22). The viscosity and the pH of the bile samples were 
unaffected by treatment with ethinyl estradiol.
The results of the gall bladder bile analysis are shown in Table 13 The administration of 
ethinyl estradiol caused a marked fall in group mean concentration of cholesterol, bile salts, and 
phospholipid. However the group mean daily bile salt secretion rate was essentially unchanged while 
the daily secretion rates of cholesterol and phospholipid fell (Table 14). The results of the group 
mean molar ratios of cholesterol, bile salts and phospholipids together with the group mean cholesterol 
saturation index are shown in Table 15 . The group mean molar ratios of cholesterol and 
phospholipids decreased slightly whereas the group mean bile salt ratio increased slightly. The group 
mean cholesterol saturation index was essentially unchanged.
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TABLE 12
Individual and group mean daily bile volume (ml) per 7—day period




- 1 137 133 128 133
0 148 142 135 142
1 116 149 138 134
2 151 148 126 142
3 149 149 155 152
4 173 153 141 156
5 190 169 144 168
6 170 168 132 157
7 162 139 142 148
8 180 65* 177 178
9 160 183 165 168
10 200 168 169 179
11 228 149 187 188






























The group mean daily molar concentration(mmol/L) of cholesterol 




Cholesterol Bile Salts Phospholipids






3 0.85 42 5.8
4 0.80 44 4.9
5 0.76 47 4:0
6 0.80 42 4.2
7 0.78 41 5.4
8 0.83 43 4.4
9 0.80 38 4.2
10 0.40 49 3.6
11 0.54 38 3.2
12 0.43 42 4.4
13 0.60 44 5.2
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TABLE 14
The group mean daily cholesterol, bile salt and phospholipid secretion rate per 7—day period
Weeks
dosed
Daily secretion rate (mmoles)
Cholesterol Bile Salts Phospholipids
-4 0.18 6.9 1.34
0 0.17 7.2 1.58
2 0.13 5.8 0.77
3 0.13 6.4 0.89
4 0.12 6.9 0.76
5 0.13 7.9 0.67
6 0.13 6.6 0.66
7 0.12 6.1 0.80
8 0.12 6.1 0.62
9 0.13 6.4 0.71
10 0.07 8.8 0.64
11 0.10 7.1 0.60
12 0.08 7.6 0.80
13 0.10 7.3 0.81
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TABLE 15
The group mean daily molar ratios of cholesterol, bile salts and phospholipid and the 
group mean cholesterol saturation index per 7—day period
Weeks
dosed
Group mean molar ratios
Mean cholesterol 
saturation indexCholesterol Bile Salts Phospholipid




1.9 81 18 36
1.9 87 12 44
3 1.7 86 12 40
4 1.6 89 10 41
5 1.5 91 8 41
6 1.8 89 9 45
7 1.7 87 12 39
8 1.8 89 10 46
9 1.9 89 10 47
10 0.8 93 7 21
11 1.5 90 8 38
12 1.0 89 10 25
13 1.2 88 11 30
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The results of the individual and group mean LAP values are given in Table 16. The group mean 
LAP levels became markedly raised after seven weeks' administration of the ethinyl estradiol, and this 
change persisted for the remainder of the dosage period (Fig. 23). The results of the other biochemical 
and haematological investigations were within the normal range.
Macroscopic findings
A t post mortem examination, minimal focal adhesions between the liver capsule and parietal 
peritoneum at the wound site were discovered in monkeys B and E. In addition, a small raised 
subcapsular area of discolouration (15 x 15 mm) was noted in the liver of monkey E adjacent to the 
adhesions. The livers of monkeys B and D were diffusely pale. The Fallopian tubes adjacent to the 
ovaries of all three monkeys were found to be bilaterally enlarged and congested and the serosal surface 
of the uterus was diffusely congested. No other macroscopic observations that could be attributable 
to treatment were recorded.
Organ weight analysis
The absolute and relative organ weights were within the normal range for rhesus monkeys in this 
age group.
Histological findings
At histological examination the pale subcapsular area in the liver of monkey E was identified as 
an area of abscess formation. In the livers of monkeys B and D, minimal portal to portal fibrous tissue 
bridging with associated mononuclear cell infiltration was seen. In addition, in monkey D, a few small 
subcapsular areas of necrosis were evident. Small secondary follicles only were noted in the ovaries. 
There was bilateral hyperplasia and congestion of the fimbrial epithelium of the Fallopian tubes and, in 
the uterus, slight dilatation of endometrial glands was observed. The vaginal epithelium showed marked 
hyperplasia with associated kératinisation. No other significant histological changes were seen.
DISCUSSION
The administration of ethinyl estradiol at a dose rate of 100 jug/kg/day produced clear changes 
in bile flow and composition. A sustained rise in bile volume was recorded but, in spite of the fact 
that the bile salt concentration decreased, the bile salt secretion rate was unchanged. A reduction in 
both concentration and secretion rate of phospholipid and cholesterol were also noted, but the 
relative molar concentration of individual bile constituents was such that the overall cholesterol 
saturation index was unchanged. The metabolism of individual bile acids was not determined.
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TABLE 16







- 1 178 249 527 318
0 253 209 292 251
1 270 206 360 279
2 369 297 281 316
3 467 280 253 333
4 715 579 292 529
5 574 259 293 375
6 686 524 215 475
7 1104 1542 282 975
8 1078 1705 315 1033
9 907 2339 333 1193
10 1722 1955 285 1320
11 1538 1417 384 1113
12 2020 2114 337 1490
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Lynn et al, (1973b) and Lynn and Williams (1975) recorded that the administration of both 
oestriol and oestrone significantly reduced bile flow and bile salt secretion rate, but relatively short 
dosing periods were employed. Morrissey et al (1977) reported a significant decrease in biliary 
cholesterol concentration following the long-term  administrations of ethinyl estradiol to baboons 
and this change was reversible following oestrogen withdrawal. Oestrone, however, increased bile 
secretion rate, producing bile that was supersaturated with cholesterol (Lynn and Williams, 1975).
With the exception of the morphological changes observed in the liver, the effects of the 
administration of ethinyl estradiol on secondary sexual characteristics, liver enzyme values and the 
reproductive tract were similar to those previously noted. The macroscopic and histological changes 
seen in the liver were probably associated with the surgical procedure and not the result of the 
administration of ethinyl estradiol.
ABSTRACT
Ethinyl estradiol was administered orally at a dosage rate of 100 jug/kg/day to a group of 3 
rhesus monkeys with an intact enterohepatic circulation for 13 weeks.
The administration of the ethinyl estradiol produced changes in bile flow and composition.
A sustained rise in bile volume was recorded but, in spite of the fact that bile salt concentration 
decreased, the bile salt secretion rate was unchanged. A reduction in both concentration and 
secretion rate of phospholipid and cholesterol were also noted, but the relative molar concentration 
of individual bile constituents was such that the overall cholesterol saturation index was unchanged. 
Biochemical investigations showed a rise in LAP values.
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C H A P T E R  F IV E
THE ORAL T O X IC IT Y  OF E TH IN Y L  ESTRADIOL  
WHEN A DM IN ISTER ED  TO POST PARTUM  
RHEUS MONKEYS AT A  DOSE RATE OF 
100/Ltg/kg/day FOR 12 WEEKS
: 64 :
INTRO DUCTIO N
Bahgat et al (1975) administered a progestogen to lactating rhesus monkeys and recorded the 
appearance of the progestogen in the milk and its affect on lactation. An extensive literature survey has 
not brought to light any published account of the effects of oestrogens when administered during 
post partum lactation to simian primates. The following study was therefore designed to investigate 
this important aspect of developmental toxicology.
M A TER IA LS & METHODS
Four wild—caught female postpartum rhesus monkeys (Macaca mulatta) were allocated to the 
study. Individual mothers and infants were housed in metal cages under standard laboratory conditions. 
One pair of mothers received 100 pg ethinyl estradiol per kg from day 5 post partum for 12 weeks. The 
other pair was undosed and acted as controls (Table 17). The drug was administered to the mothers by 
gavage. The mothers were fed a complete dry diet supplemented by fresh fruit every second day and 
wholemeal bread each weekday.
Food consumption of the mothers and signs of ill health in mothers or infants were monitored 
daily. Bodyweights of mothers and infants were recorded before dosing began and then at weekly 
intervals. Biochemical investigations of serum alanine aminotransferase and serum leucine amino pepti­
dase levels of mothers and infants were carried out before dosing and then after 1, 3 ,5 ,7 ,9  and 11 weeks' 
dosing. The concentrations of ethinyl estradiol present in both serum samples from mother and infant 
and in milk samples from the dam were determined by radioimmunoassay before dosing started and 
then after 4, 8 and 12 weeks' dosing. (Warren and Fotherby 1974). Milk sampling was facilitated by 
intravenous administration of 5 i.u. oxytocin.
On completion of the dosing period, the infant monkeys were killed and immediately afterwards 
a full macroscopic examination was made, during which the brain, pituitary, heart, lungs, liver, spleen, 
pancreas, thymus, prostate, uterus, kidneys, thryoids, adrenals, gonads and seminal vesicles were 
removed and weighed. Small portionsof these tissues, together with aorta, trachea, lymph nodes, gall 
bladder, urinary bladder, salivary gland, tongue, oesophagus, stomach, duodenum, jejunum, ileum, 
caecum, colon, skin, skeletal muscle, sciatic nerve, eye, vagina and vulva, together with any macroscopic 
abnormality, were placed in 10% buffered formalin fixative. The tissues were routinely processed in 
paraffin wax, sectioned at 5 pm and stained with haematoxylin and eosin. Additional pieces of liver and 
kidney were placed in formol calcium, sectioned at 12 pm and stained for fat with Oil Red 0 .
The mothers were maintained for a further 12 weeks' observation period.
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TABLE 17
Data relating to individual monkeys at the start of the dosage period
Dosage group Adult animal number Sex of infant
Undosed Control 202 6
42 9





The male infant of monkey 2139 showed slight reddening of the perineum from week 3 of dosing 
onwards. By week 9, reddening and oedema were considerable and in addition the mammary glands 
appeared prominent. These changes persisted until the animal was sacrificed at week 12 (Fig. 24—25). 
The female infant of monkey 109 showed slight reddening of the perineum through weeks 5, 7 and 8. 
The perineum and mammary glands of the untreated control infants were unaffected.
Post partum menses were not recorded in any of the animals during the experimental period. 
None of the treated females returned to menses during the 12 week recovery period and only one of 
the control animals returned to cycle 6 weeks after weaning.
Bodyweight
The weights of the infant monkeys are shown graphically in Figure 26. The small number of 
animals used precludes definite conclusions, but there is some indication that the infants of the dams 
receiving 100 pg ethinyl estradiol per kg per day showed only slightly slower growth rates than the 
animals in the control group. Although no attempt was made to measure milk yield, the fact that this 
difference in growth rates was marginal suggests that milk yield was not significantly depressed.
The weights of the mothers are shown graphically in Figure 27. Administration of ethinyl 
estradiol caused a slight loss of bodyweight when compared to the controls.
Biochemical investigations
Administration of ethinyl estradiol to the mothers had no adverse effect on the LAP and SAIT  
levels. Figure 28 shows the mean SAIT values of dosed adults and infants depicted graphically.
Serum and milk ethinyl estradiol concentrations
In the conjugated fraction of plasma, ethinyl estradiol was detected after 4 (400 pg/ml), 8 
(200 pg/ml) and 12 weeks' dosing (130 pg/ml) in adult monkey 109 only. All other values in the 
conjugative fraction were negative. Ethinyl estradiol was not detected in any of the milk samples nor 




Figure 24 Maie infant of monkey 213 
Posterior aspect showing marked development of the sex skin
.. U  ■*
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Figure 25 Male infant of monkey 213 



































































The mammary glands of the male infant of monkey 2139 were prominent and the teats 
pendulous. In this animal, the sex skin extended from the perineal region, medio—posteriorly to the 
knee, antero—dorsally to the sacral region and backwards along the tail. The sex skin was folded, 
reddened and appeared oedematous. The scrotal skin was erythematous. Macroscopic abnormalities 
were not observed in any of the other infants.
Organ weight analysis
The organ weights of the treated infant monkeys were comparable to those of the untreated 
control group.
Histological findings
Histological examination of the mammary gland of the male infant from monkey 2139 revealed 
slight ductal proliferation (Fig. 29). No other morphological abnormalities were encountered that 
could be attributed to treatment.
DISCUSSION
The results demonstrate that a physiological change may be induced in the infants of the 
mothers dosed with ethinyl estradiol indicating that the oestrogen is secreted through the milk.
Bahgat et al (1975) showed by radioimmunoassay that progestogens may similarly 
appear in milk. It is of interest to note that the male rhesus monkey is born showing swelling and 
turgescence of the scrotum (Wislocki, 1933). This naturally occurring physiological effect would 
appear to be due to the markedly increased circulating levels of oestradiol and oestrone during the last 
few days of pregnancy in the rhesus monkey (Resko et al, 1975 ; Weiss et al, 1976 ; Challis et al 1977).
In contrast to previous observations, administration of ethinyl estradiol to post—partum rhesus 
monkeys failed to induce any changes in liver enzyme values. It is possible that the metabolism of 
ethinyl estradiol in the lactating animal may differ from that of the non—lactating animal. Weiss et al 
(1973) have observed that in the post—partum rhesus monkey, lactation prolongs the morphological and 
functional integrity of the corpus luteum of pregnancy.
In addition, the experiment showed that once lactation was established, the administration of 




Figure 29 Male infant of monkey 213 
Mammary gland showing ductal proliferation ( ).
Note also stroma (st). Haematoxylin and eosin (x160).
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ABSTRACT
Ethinyl estradiol was administered orally to two post—partum lactating rhesus monkeys at a 
dosage rate of 100 jug/kg/day for 12 weeks. Two other post—partum animals were maintained as 
undosed controls.
Clinical and histological changes were induced in the infants of the mothers dosed with ethinyl 
estradiol indicating that the oestrogen was secreted through the milk. Lactation did not appear to be 
suppressed. Following cessation of treatment, hormone withdrawal bleeding did not occur.
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C H A P T E R  S IX
THE ORAL T O X IC IT Y  OF E TH IN Y L  ESTRADIO L  
WHEN A D M IN ISTER ED  TO NEO NATAL  
RHESUS MONKEYS A T  A DOSE RATE OF 
100 pg/kg/day FOR 13 WEEKS
: 75
IN TRO DU CTIO N
It has long been recognised that the immature animal is not merely a miniature of the mature. 
Recently we have begun to appreciate the practical importance of developmental toxicology 
(Done, 1964). Differences in drug toxicity, in drug distribution, in quantitative and qualitative 
sensitivity of target organs, in detoxification mechanisms and in excretory mechanisms such as 
efficiency of renal function might affect the toxicity of a compound in the neonate. The purpose of 
this study was to evaluate the oral toxicity of ethinyl estradiol in the neonatal rhesus monkey.
M ATERIALS AND METHODS
Four neonatal rhesus monkeys (Macaca mulatta) aged not less than 3 weeks were allocated 
to the study. Two monkeys were given 100 jug ethinyl estradiol/kg/day by oral 
gavage for 13 weeks. The other two monkeys were not dosed and were maintained 
as untreated controls (Table 18). Throughoutthe study the monkeys were housed individually with 
their mothers in metal cages.
Clinical observations for signs of ill health were made daily. Bodyweight was recorded at weekly 
intervals. Haematological investigations comprising total red and white cell counts, differential white 
cell counts, haemoglobin, and packed cell volume were performed at monthly intervals. Biochemical 
investigations consisting of serum alanine aminotransferase (SAIT), serum leucine aminopeptidase 
(LAP) and serum aspartate aminotransferase (SA sT) were also carried out at monthly intervals.
On completion of the dosing period the animals were killed and immediately afterwards a full 
macroscopic examination was performed. The adrenals, brain, gonads, heart, kidneys, liver, lungs, 
pancreas, pituitary, prostate, spleen, thymus, thyroids and uterus were removed and weighed. Small 
portions or the whole of these tissues together with samples of aorta, sternal bone marrow, cervix, 
caecum, colon, duodenum. Fallopian tubes, eyes, gall bladder, ileum, jejunum, cervical and mesenteric 
lymph nodes, mammary glands, oesophagus, seminal vesicles, skeletal muscle, sciatic nerve, skin, 
submandibular salivary gland, stomach, trachea, tongue, urinary bladder, vagina and vulva were placed 
in 10% buffered formalin fixative. The tissues were routinely processed in paraffin wax, sectioned at 
5 jum and stained with haematoxylin and eosin. Additional pieces of liver and kidney were placed in 
formol calcium, sectioned at 12 /im and stained for fat with Oil Red 0 .
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TABLE 18
Data relating to individual animals at commencement of dosing
Animal No./Sex Dosage Group Age at start






Liver samples were taken and fixed in 4% glutaraldehyde buffered with 0.05 M cacodylate to 
pH 7.3 at 4°C. Three 1 mm^ blocks of tissue from each animal were processed in 1% osmium 
tetroxide buffered with 0.05 M cacodylate to pH 7.3, dehydrated in alcohol and embedded in epoxy 
resin. Survey sections 1 nm thick were cut and stained with 1% toluidine blue for examination with 
the light microscope. Silver/gold ultra—thin sections of representative areas were mounted on copper 
grids and subsequently stained with lead citrate and uranyl acetate. These sections were examined 
using a Philips EM 300 electron microscope operating at 60 KV. Selected areas were photographed on 
Kodak Fine Grain Positive 35 mm film and enlarged as necessary.
RESULTS 
Clinical signs
During the second week of dosing, slight stimulation of the sex skin was apparent in the treated 
animals. This change was progressive and, after 12 weeks, skin folding together with erythema was 
generalised. In addition, the teats of both treated monkeys became enlarged and 
pendulous. No adverse effects were observed in bodyweight gain in the treated animals.
Laboratory investigations
During the dosing period group mean LAP values increased in treated animals, whereas in the 
undosed controls, LAP values fell. This has been illustrated graphically in Figure30. Significant 
differences in group mean SAsT and SAIT values were not observed. (Table 19). No significant 
haematological abnormalities were noted.
Macroscopic findings
The seminal vesicles of monkey 294d and the cervix, uterus and Fallopian tubes of monkey 
3169 were markedly enlarged in comparison to those of the control animals. The cervix and 
uterus of monkey 3169 measured 15 mm and 10 mm in diameter respectively, whereas the cervix 
and uterus on monkey 1589 both measured 1 mm in diameter only.
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Figure 30 



















0 4 8 12
SAIT 0 34 35 24 28
100 14 20 23 37
SAsT 0 54 51 34 36
100 38 48 44 66
LAP 0 635 360 282 263
100 581 437 661 881
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Organ weight analysis
The seminal vesicles and the uterus of the treated animals were markedly enlarged, weighing 
2.60 g and 1.19 g respectively (Table 20a and 20b). All other values were considered to be within the 
normal range.
Histological findings
No definite morphological abnormalities that could be attributed to treatment were observed in 
the livers of the two monkeys given ethinyl estradiol.
However, in the treated male animal oestrogenic effects were noted in the prostate, seminal 
vesicles and mammary glands. Moderate focal squamous metaplasia of both the prostatic acinar and 
ductular epithelium and of the transitional epithelium of the prostatic urethra was seen (Fig. 31 ). 
The seminal vesicles showed marked diffuse hyperplasia and in the mammary gland slight acinar 
hyperplasia with lobular formation was evident.
In the treated female monkey, oestrogenic effects were noted in the uterus. Fallopian tubes, 
cervix, vagina and mammary gland. Marked diffuse hyperplasia of the endometrium and myometrium 
was apparent in the uterus. In addition, one endometrial gland showed moderate cystic dilatation.
The fimbrial epithelium of the Fallopian tubes was diffusely hyperplastic. The cervical 
mucosal epithelium showed diffuse hyperplasia and in some areas small foci of squamous epithelium 
were observed. In the vagina, marked diffuse hyperplasia andcornification of the stratified sqamous 
epithelium were seen. The changes in the mammary glands were similar to those in the mammary glands 
of the treated male monkey.
Ultrastructural findings
The ultrastructure of the livers of the treated animals was essentially similar to that of the livers 
of the control group.
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TABLE 20a 








337d 0 950 0.44 —
1589 0 1016 - 0.13
294d 100 1250 2.60 -
3169 100 878 - 1.19
TABLE 20b 








337d 0 0.046 —
1589 0 - 0.013
294J 100 0.208 —
3169 100 - 0.0136
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Figure 31 Rhesus monkey 294d 
Transverse section of prostate showing focal squamous metaplasia 
of acinar epithelium ( ).
Note also prostatic stroma (st) and acini (a). Haematoxylin and eosin(x 80.
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DISCUSSION
The results of the experiment show that ethinyl estradiol, when administered to neonatal rhesus 
monkeys, stimulated the development of the seminal vesicles in the male and of the uterus in the 
female. The development of the seminal vesicles was an unexpected change and suggests that in the 
rhesus monkey, the seminal vesicles and Mullerian ducts may have at least in part some common 
embryological origin, van Wagenen (1935) reported hyperplasia of the fibromuscular stroma of the 
seminal vesicles when "theelin" was administered to immature rhesus monkeys. Hisaw and Hisaw 
(1961 ) concluded that the outstanding effect of oestrogens on the uterus was that of growth, and so 
the development of the uterus in the neonate was predictable. The dependence of the female 
reproductive tract on ovarian hormones is strikingly demonstrated by the profound atrophy of the 
genital tract that follows surgical removal of the ovaries. The involuted uterus of a ovariectomised animal 
can be restored to its normal size in 2 or 3 weeks by daily injections of adequate amounts of oestrogens 
(Allen 1927 ; 1928).
The anabolic effects of oestrogens in other species have long been appreciated. In this study no 
appreciable difference was evident in the rate of growth of the treated animals compared with that of 
the controls. However, 13 weeks' treatment may be insufficient for such differences to emerge.
The effects of oestrogens on the sex skin, the serum liver enzymes, the mammary glands, the 
Fallopian tubes,the cervix and the vagina in the neonate were essentially similar to those in adults. The 
effects of oestrogenic stimulation of the prostate of the castrated immature rhesus monkey have been 
described by Zuckerman (1938). The prostate greatly increased in size and while the epithelium of the 
true prostatic glands was unchanged, hyperplasia and metaplasia had taken place in the epithelium of 
the urethra, vagina masculina, terminal parts of the ejaculatory ducts and collecting ducts, van 
Wagenen (1935) also recorded squamous metaplasia of the epithelium of the colliculus seminalis and 
the bulbous and cavernous urethra following oestrogen administration.
ABSTRACT
Ethinyl estradiol was administered orally to two neonatal rhesus monkeys at a dosage rate of 
1 0 0 /ig/kg/day for 13 weeks. Two other neonatal rhesus monkeys were maintained as undosed 
controls.
With the exception of the stimulation of the development of the seminal vesicles in the male 
and of the uterus in the female, the changes induced by ethinyl estradiol were similar to those seen 
in adult rhesus monkeys.
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C H A P T E R  S E V E N
A TER A TO G ENIC  STUDY W ITH E TH IN Y L  ESTRADIOL  
WHEN A D M IN ISTER ED  TO RHESUS MONKEYS  
BY SUBCUTANEOUS INJECTION A T  A DOSE RATE 
OF 50 ptg/kg/day
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IN TRO DU CTIO N
The experimental use of non—human primates to investigate abnormalities of intrauterine 
development essentially began with studies of thalidomide after the drug had been shown to be 
teratogenic in man. The sensitive period of organogenesis in the rhesus monkey, approximately from  
day 20 to day 45 of gestation (Wilson, 1971), compares well with that of man, which Lenz (1964) 
estimates to extend from day 20 to day 36 of gestation (34th to 50th day from last menses).
Morris and van Wagenen (1966) administered oestradiol dipropionate to six monkeys at dosage 
rates from 4 mg — 25 mg/day and diethylstilboestrol at dosage rates from 1 mg — 250 mg/day to 
fourteen monkeys after implantation (days 18 — 167). Dosing was not confined to the period of 
organogenesis and they reported that no foetal abnormalities were observed nor was the incidence of 
abortion greater than that normally encountered in their primate colony.
With the exception of this report from Morris and van Wagenen, there would appear to be no 
other published studies of the teratogenicity of oestrogens in rhesus monkeys.
M A TER IA LS AND METHODS
Ten wild—caught female rhesus monkeys (Macaca mulatta) were selected and housed separately 
in metal cages. Following a period of acclimatisation, the animals were allocated to treatment groups. 
(Table.21 ).AII monkeys were fed a complete dry diet, supplemented by fresh fruit every second day 
and wholemeal bread each week-day. Water was freely available at all times.
Clinical observations were made daily to determine the stage of the menstrual cycle of each 
animal. During the 10th, 11th and 12th days of the menstrual cycle (first day of menses being day 0 
of the menstrual cycle and 11th day of the menstrual cycle being day 0 of gestation), each female was 
housed with a mature male rhesus monkey of proved fertility, to allow mating to take place. Pregnancy 
was determined by a chorionic gonadotrophin bio—assay (Mouse Uterine Test, Wilson et al, 1970) of a 
serum sample taken at day 17 of the gestation period and confirmed by rectal palpation of the uterus. 
Food intake was monitored daily and bodyweight recorded at weekly intervals.
The ethinyl estradiol was dissolved in a solution of 2%% ethyl alcohol in water, to form a 
concentration of 0.01 g% w/v. The ethinyl estradiol was then administered daily by subcutaneous 
injection at a dosage rate of 50 ytg/kg. Monkey 1759 was dosed from day 23 to day 45 of gestation, 
monkey 2019 from day 29 to day 45, monkey 2149 from day 24 to day 45 and monkey 2159 from 
day 20 to day 45.
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TABLE 21


















After the 100th day of gestation, a caesarian section was performed, during which the total 
conceptus was removed. The foetus was immediately killed and the weight of the entire conceptus, 
foetus, placenta and foetal fluids determined. The sex of the foetus and the placental type were 
noted. The foetus was then examined radiographically in two planes for skeletal observations using an 
A.F. Dean Mobile X—ray unit, operating at 42 kv and 300 MA for 0.24 seconds, with a Kodak 
Industrex C54 film. After an external examination a full macroscopic post mortem examination was 
performed, during which the adrenals, brain, gonads, heart, kidneys, liver, lungs, pancreas, pituitary, 
prostate, spleen, thymus, thyroids and uterus were removed and weighed. Small portions of these 
tissues were taken from the foetuses derived from treated mothers together with aorta, cervix, caecum, 
colon, duodenum, epididymis. Fallopian tubeseyes, ileum, jejunum, cervical and mesenteric lymph 
nodes, mammary glands, placenta, oesophagus, skeletal muscle, sciatic nerve, skin, submandibular 
salivary gland, seminal vesicles, stomach, umbilical cord, trachea, tongue, urinary bladder, vagina and 
vulva, were placed in 10% buffered formalin fixative. The tissues were routinely processed in paraffin 
wax, sectioned at 5 /im and stained with haematoxylin and eosin.
RESULTS
Maternal data
The extent and duration of vaginal bleeding varied considerably between monkeys (Fig. 32). 
However, vaginal bleeding generally was sporadic and appeared to be unrelated to treatment.
Two of the treated animals, 1759 and 2019, aborted after 54 days of gestation. There were no 
abortions amongst the control animals.
Analysis of bodyweight and food consumption data showed no obvious adverse effects.
Foetal data
The weights of the entire conceptus, foetus, placenta and amniotic fluids derived from treated 
animals were essentially comparable to those of the control group (Table 22). In addition all foetuses 
from both groups had double discoid placentae.
The absolute organ weights are presented in Table 23. Organ weights were essentially comparable 





















































Individual foetal and placental data
Group Foetus No. Wt. of entire
Foetus Placenta Amniotic fluid
conceptus (g) Sex Wt. (g) Type Wt.(g)
Wt. (g)
1 214 392 6 168 Double 92 132
50 jLig/kg 
day
215 396 9 134 Double 91 171
8 283 â 132 Double 50 73
2 42 318 â 129 Double 76 83
Undosed
controls
134 313 â 125 Double 66 101
157 276 9 130 Double 61 69
166 267 9 112 Double 54 82
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Skeletal dimensions, vertebral and sternebral counts showed little variation between individuals 
with no treatment related trends. Fig. 33—34 illustrate the antero—posterior and lateral radiographs of 
the foetus derived from monkey 2149 and Fig. 35—36 of the foetus derived from monkey 2159*
Macroscopic post mortem examination revealed no abnormalities in any foetus.
Histological examination of the foetuses from monkeys 2149 and 2159 showed no abnormality. 
Histological examination of aborted material from monkeys 1759 and 2019 gave positive confirmation 
of pregnancy.
DISCUSSION
The results of this investigation show that ethinyl estradiol has no apparent teratogenic effect 
when administered to rhesus monkeys at a dosage rate of 50 /ig/kg/day during the period of 
organogenesis. However, further evaluation with higher dosage groups nearer the maximum tolerated 
dose for adult female monkeys is necessary for a full teratological screen. The possibility that ethinyl 
estradiol in the rhesus monkey is embryotoxic as manifested by early embryonic death and abortion 
cannot be excluded on the data available.
These results are not inconsistent with those reported by Morris and van Wagenen (1966) 
although the incidence of abortion in their study was no greater than that normally encountered in 
their primate colony.
ABSTRACT
Ethinyl estradiol was administered during the period of organogenesis to a group of four 
pregnant rhesus monkeys at a dosage level of 50 /ig/kg/day. Six undosed pregnant monkeys were 
maintained as procedural controls. After the 100th day of gestation, caesarian sections were performed 
and the conceptus examined.
Two treated animals aborted indicating that ethinyl estradiol may cause early embryonic death 
at this dosage level. No teratogenic effects were evident in the two other treated foetuses derived by 
caesarian section.
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Figure 33 Antero—posterior radiograph of foetus from monkey 2149
1 4
I
Figure 34 Lateral radiograph of foetus from monkey 2149
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Flà •
Figure 35 Antero—posterior radiograph of foetus from monkey 2159.
R  2 10
I
Figure 36 Lateral radiograph of foetus from monkey 2159
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C H A P T E R  E IG H T
THE O RAL T O X IC IT Y  OF E TH IN Y L  ESTRADIO L  
(500 /ig/kg/week) AND CHENO DEO XYCHO LIC ACID  
(45 mg/kg/day WHEN A DM INISTER ED  TO  
BABOONS FOR 26 WEEKS
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INTRO DUCTIO N
Chenodeoxycholic acid, one of the primary bile acids, has been successful in dissolving human 
cholesterol gall-stones. The hepatotoxicity of chenodeoxycholic acid when administered orally to 
rhesus monkeys (Dyrszka et al., 1975 ; Dyrszka et al., 1976 ; Heywood and Sortwell 1977 (b) ; 
Fedorowski et al., 1977) and to baboons (Morrissey et al., 1975 ; Heywood and Sortwell 1977 (a) ) 
is well established. Ethinyl estradiol when administered orally to rhesus monkeys also disturbs liver 
function. The purpose of the study therefore was to assess the combined oral toxicity of 
chenodeoxycholic acid and ethinyl estradiol. Female non—human primates were chosen because 
prevention and treatment of cholesterol gall-stones may be most necessary for patients during child­
bearing years. Palmer and Heywood (1974) and McSherry et al (1976) have already recorded foetal 
toxicity of chenodeoxycholic acid both in rhesus monkeys and baboons respectively.
M A TER IA LS AND METHODS
Eight wild—caught female baboons (Papio anubis or Papio cynocephalus) were selected and 
housed separately in metal cages. A four—week period was allowed for preliminary investigations to 
take place and for the animals to adjust to their new environment. The monkeys were fed a complete 
dry diet, supplemented by fresh fruit every second day and wholemeal bread each weekday. Water was 
freely available at all times. The animals were divided into three groups. Two monkeys were given 
500 ;^g/kg/week ethinyl estradiol together with 45 mg/kg/day chenodeoxycholic acid, three monkeys 
were given 45 mg/kg/day chenodeoxycholic acid and three monkeys were maintained as controls 
(Table 24).
Food and water consumption, together with clinical observations for signs of ill health, were 
monitored daily. Bodyweight was recorded at weekly intervals. Veterinary examinations were 
performed before dosing commenced and after 6 ,1 2 , 16 and 22 weeks' dosing. Biochemical 
investigations, comprising serum alanine amiontransferase, serum aspartate aminotransferase and 
serum leucine aminopeptidase, were carried out before dosing commenced and after 4 ,8 , 16 and 25 
weeks' dosing for groups 1 and 2 and after 4, 8, 12, 16, 20, 24 and 26 weeks' dosing for group 3.
On completion of the dosing period, the animals were killed and immediately afterwards a full 
macroscopic examination performed, during which the adrenals, brain, gonads, heart, kidneys, liver, 
lungs, pituitary, spleen, thymus, thyroids and uterus were removed and weighed. Small portions of 
these tissues, together with aorta, sternal bone marrow, cervix, caecum, colon, duodenum. Fallopian 
tube, eyes, gall bladder, ileum, jejunum, cervical and mesenteric lymph nodes, mammary glands, 
oesophagus, skeletal muscle, sciatic nerve, skin, submandibular salivary gland, stomach, trachea, tongue, 
urinary bladder, vagina and vulva, together with any macroscopic abnormality, were placed in 10% 
buffered formalin fixative. The tissues were routinely processed in paraffin wax, sectioned at 5 jum 
and stained with haematoxylin and eosin. Additional pieces of liver and kidney were placed in formol 
calcium, sectioned at 12 jjim and stained for fat with Oil Red 0 .
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TABLE 24
Data relating to individual animals at commencement of dosing







2 45 mg/kg/day 832 4.75
chenodeoxycholic 834 4.35
acid 836 2.85
3 45 mg/kg/day 863 3.95
chenodeoxycholic acid 






There was suppression of menstruation in both baboons in group 3 throughout the dosing period 
and vulval enlargement was seen in both animals from the eleventh week of dosing onwards. During 
the last two weeks of dosing, baboon 8639 became dull and lost condition slightly. There were no 
definite adverse signs that could be related to the administration of chenodeoxycholic acid alone. 
Bodyweight, food intake and water consumption were not affected.
Laboratory investigations
Group mean SAsT, SAIT and LAP values are presented in Table 25. After 4 week's dosing the 
mean LAP values were raised in group 2 and after 8 weeks dosing the mean LAP values in group 3 
were raised. These changes persisted for the remainder of the dosing period. Both the mean SAsT and 
SAIT values in groups 2 and 3 showed transient increases after initiation of treatment but were not as 
consistently raised as were the mean LAP values.
Macroscopic findings
In baboons 8639 and 8649 there was bilateral enlargement and congestion of the Fallopian tubes 
adjacent to the ovary. In baboon 8639 the liver was pale and in baboon 8649 there were small areas 
of discolouration throughout the capsular surface of the liver. In baboon 8349 the liver was dark and 
the lobular appearance was accentuated. No other macroscopic abnormalities could be attributed to 
treatment.
Organ weight analysis
The relative and absolute organ weights were considered to be within the normal range and there 
were no group differences.
Histological findings
The livers of both baboons in group 3 showed minimal bile duct proliferation with occasional 
portal—to—portal bridging, and slight periportal chronic inflammatory cell infiltration (Fig. 38). Both 
animals showed bilateral hyperplasia of the fimbrial epithelium of the Fallopian tubes, and hyperplasia 
and cornification of the vaginal squamous epithelium. In baboon 8639 a small focus of squamous 
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mFigure38 Baboon 8639 
Liver showing bile duct hyperplasia with portal to portal bridging. 
Haematoxylin and eosin (x50).
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The livers of the baboons in group 2 showed minimal or moderate bile duct proliferation with 
portal to portal bridging, portal fibrosis and periportal mixed inflammatory cell infiltration.
No other morphological abnormalities were observed that were considered to be related to 
treatment.
DISCUSSION
The results show that the hepatotoxicity of both chenodeoxycholic acid (45 mg/kg/day) and 
ethinyl estradiol (500 jug/kg/week) in the baboon was essentially similar to that of chenodeoxycholic 
acid alone (45 mg/kg/day). Morrissey et al (1975) and Heywood and Sortwell (1977a) recorded 
significant increases in liver enzyme values associated with varying degrees of bile duct proliferation 
and periportal mononuclear cell infiltration when chenodeoxycholic acid was given to baboons at 
a dosage rate of 38 mg/kg/day and 45 mg/kg/day respectively. The ultrastructural changes in the 
liver associated with chenodeoxycholic acid treatment have been recorded by Dyrszka et al (1976). 
They described in addition to light microscopical findings, bile canalicular bleb formation and 
hypertrophy of the hepatocyte smooth endoplasmic reticulum. The toxicity of chenodeoxycholic 
acid is partly attributed to its metabolite, lithocholic acid. In the intestine, chenodeoxycholic acid 
undergoes 7—a —dehydroxylation by bacterial action. Administration of chenodeoxycholic acid 
results in an increase in lithocholic acid in the bile (Dyrszka et al., 1975 ; Morrissey et al, 1975). 
Mosbach et al, (1975) and Fedorowski et al (1977) demonstrated that depression of bacterial action 
in the intestine by antibiotic therapy inhibited bacterial dehydroxylation and minimised liver 
damage. Hofman et al (1977) have reported that lithocholic acid in the chimpanzee is solely excreted 
in the bile in its conjugated form. This degree of sulphation was considered to resemble that of man 
and so they suggest that the chimpanzee may be a more suitable animal model for the toxicity of 
lithocholic acid than the rhesus monkey. Suzuki et al (1977) have also recorded that administration 
of chenodeoxycholic acid to squirrel monkeys did not alter the proportion of lithocholic acid in 
biliary bile acids and this was associated with a lack of hepatoxicity when dosage levels were as high 
as 80 mg per kg for 52 weeks.
The effects of ethinyl estradiol on the fimbrial epithelium of the Fallopian tubes, the cervical 
epithelium and the vaginal epithelium were similar to those previously recorded.
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ABSTRACT
Ethinyl estradiol (500 /ig/kg/week) and chenodexoycholic acid (45 mg/kg/day) were 
administered orally to two female baboons for 26 weeks, chenodeoxycholic acid (45 mg/kg/day) was 
administered orally to three female baboons for 26 weeks and three female baboons were maintained 
as undosed controls.
The results indicate that the combined hepatoxicity of ethinyl estradiol and chenodeoxycholic 
acid was no greater than that induced by chenodeoxycholic acid alone.
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CHAPTER NINE
THE PRENATAL A D M IN IS TR A TIO N  OF DIETHYLSTILBO ESTRO L  
TO RHESUS MONKEYS A T A  
DOSE RATE OF 1 mg/kg/day FOLLOWED BY A
POSTNATAL RECOVERY PERIOD OF 84 WEEKS
103
INTRO DUCTIO N
The experimental administration of androgens to pregnant rhesus monkeys at an appropriate 
stage of gestation — that is, from approximately the 40th to the 90th day of gestation, — has been 
shown to transform female foetuses into female pseudohermaphrodites (van Wagenen and Hamilton,
1943 ; van Wagenen, 1949 ; Wells and van Wagenen, 1949 : Dantchakoff, 1950 ; Wells and van Wagenen, 
1954 ; Young et al, 1964 ; Goy, 1966 ; Phoenix et al, 1967, and Goy, 1968). Apart from the report 
from Morris and van Wagenen (1966) who administered oestradiol and diethylstilboestrol to pregnant 
rhesus monkeys there appears to be no other published account of the administration of oestrogens to  
pregnant simian primates.
The rhesus monkey may be an appropriate animal model for the study of the foetotoxic effects 
of diethylstillboestrol because the biotransformation, the nature of the metabolites and the route of 
excretion of diethylstilboestrol closely resemble those of man (Metzler, et al, 1977).
M ATERIALS AND METHODS
Four wild—caught female rhesus monkeys (Macaca mulatta) were selected and housed separately 
in metal cages. Clinical observations were made daily to determine the stage of the menstrual cycle 
of each animal. During the 10th, 11th and 12th days of the menstrual cycle (first day of menses being 
day 0 of the menstrual cycle and the llth day of the menstrual cycle being day 0 of gestation), each 
female was housed with a mature male rhesus monkey of proved fertility to allow mating to take 
place (van Wagenen, 1945). Pregnancy was confirmed by rectal palpation of the uterus. Food intake 
was monitored daily and bodyweight recorded at weekly intervals. Diethylstilboestrol was 
administered daily by intramuscular injection at a dose level of 1 mg/kg from the 45th day of gestation 
until parturition, which in the rhesus monkey occurs at approximately the 168th day of gestation.
The infant rhesus monkeys were then maintained for a recovery period of 84 weeks. Clinical 
observations were made daily and bodyweight recorded every four weeks. When the infants weighed 
1 kg (after 20 weeks) they were weaned ; subsequently food consumption was monitored daily and 
bodyweight recorded at weekly intervals. Laboratory investigations were performed just before the 
animals were killed. The haematological investigations comprised counts of total red and white cells, 
differential white cells, platelets and reticulocytes, and estimations of packed cell volume, haemoglobin, 
prothrombin index and erythrocyte sedimentation rate. The biochemical investigations comprised 
determination of plasma urea, plasma glucose, serum proteins (total and differential) serum alanine 
aminotransferase, serum alkaline phosphatase, leucine aminopeptidase, serum aspartate aminotrans­
ferase, serum bilirubin, sodium and potassium levels.
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On completion of the recovery period, the infant rhesus monkeys were killed, and immedately 
afterwards a full macroscopic post mortem examination was performed during which particular 
attention was paid to the reproductive tract. The adrenals, brain, heart, kidneys, liver, lungs, 
pancreas, pituitary, prostate, seminal vesicles, spleen, thymus and thyroids were removed and 
weighed. Small portions or the whole of these tissues together with samples of aorta, cervix, caecum, 
colon, duodenum, eyes, gonads, gall bladder, ileum, jejunum cervical and mesenteric lymph nodes, 
mammary glands, uterus, oesophagus, skeletal muscle, sciatic nerve, skin, submandibular salivary 
gland, stomach, trachea, tongue, urinary bladder, vagina, and vulva were placed in 10% buffered 
formalin fixative. The tissues were routinely processed in paraffin wax, sectioned at 5 /im and 
stained with haematoxylin and eosin. Additional pieces of liver and kidney were placed in formol 
calcium, sectioned at 12 ^im and stained for fat with Oil Red O.
RESULTS
Maternal data
Beginning at the 45th day of gestation, diethylstlboestrol was injected intramuscularly at a 
dosage rate of 1 mg/kg/day until termination. Two of the pregnant females, 459 and 509 aborted after 
31 and 87 days of treatment respectively. The pregnant female 1779 gave birth to a male infant on the 
168th day of gestation after receiving a total of 655 mg of diethylstilboestrol. The pregnant female 
1859 gave birth to a female infant on the 169th day of gestation after receiving a total of 642 mg of 
diethylstilboestrol. The average gestation period of untreated control rhesus monkeys maintained 
at the Huntingdon Research Centre is 166.8 days with a range of 156—177 days (Heywood, 1974). 
Food consumption and bodyweight of monkeys 1779 and 1859 were not adversely affected.
Infant data
Both infants weighed 425 g at birth. The mean birth weight of rhesus monkeys maintained at 
the Huntingdon Research Centre is 440 — 50 g (Heywood, 1974). The infant monkeys were 
maintained for a recovery period of 84 weeks. At birth, both infant monkeys showed slight folding 
and reddening of the sex skin. These changes persisted for 12 weeks in the male infant of monkey 
1779 and for 10 weeks in the female infant of monkey 1859. Both infants were weaned at 
approximately 20 weeks of age when they weighed 1 kg. The bodyweight gain during the first year, 
while fluctuating, was similar to that normally encountered in untreated control animals at the 
Huntingdon Research Centre (Heywood, 1974).
With the exception of a slightly lower total serum protein level in the infant monkey 1779 and 
a slightly raised SAsT value in the infant of monkey 1859 the results of the preterminal laboratory 
investigations were within the normal range.
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A t post mortem examination, the male infant of monkey 1779 weighed 1.75 kg and the female 
infant of monkey 1859 weighed 2.20 kg. With the exception of the testes of the male infant which 
were found in the inguinal region, the external genitalia were normal in appearance. Internally, both 
the prostate and seminal vesicles were found to be poorly developed. The right and left seminal 
vesicles weighed only 0.148 g and 0.188 g respectively. The prostate was located by the examination 
of the prostatic urethra for the opening of the prostatic ducts and weighed 0.128 g. The combined 
prostate and seminal vesicle weight for animals weighing 1.71 kg — 121 g (mean of 6) is normally 
0.90 — 0.14 g. In the female infant, the only abnormalities seen in macroscopic examination were 
prominent folds in the vaginal mucosa. The remaining relative and absolute organ weights were 
considered to be within the normal range for animals in this age group.
At histological examination the testes of the male infant were found to be immature, with 
spermatogenesis proceeding to the spermatocyte stage only. No morphological abnormalities were 
found in the prostate and seminal vesicles, the appearance of which was essentially similar to that 
encountered in immature male rhesus monkeys of this age group. The reproductive tract of the female 
infant was normal. Only small secondary follicles were evident in the ovaries and shallow endometrial 
glands were noted in the uterus. The cervix and vagina were lined by well developed columnar and 
stratified squamous epithelia respectively. No other morphological changes were seen that could be 
attributable to treatment with diethylstilboestrol.
DISCUSSION
The results indicate that prenatal exposure to deithylstilboestrol partially inhibits the normal 
development of the male accessory sex glands of rhesus monkeys. Further evaluation with larger 
groups of monkeys is necessary to confirm these preliminary investigations. Morris and van Wagenen 
(1966) reported that no foetal abnormalities were observed when diethylstilboestrol was 
administered to 14 pregnant macaques. The dosage rate and dosing period varied considerably, 
precluding valid comparison. In addition, a postnatal recovery period was not allowed.
Maternal plasma levels of steroidal oestrogens increase progressively during pregnancy, 
particularly during the last seven days (Challis et al, 1977) and are thought to be placental in origin. 
The steroid concentration of oestradiol in maternal plasma is higher than in amniotic fluid, although 
this relationship is reversed for oestrone, especially during the 20 days preceding delivery. Such 
changes are undoubtedly responsible for the swelling and turgescence of the scrotum seen at birth in 
male rhesus monkeys (Wislocki, 1933). In this experiment, diethystilboestrol had a marked effect 
on the sex skin of both infants, suggesting that the foetuses were exposed to high concentrations of 
diethylstilboestrol.
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Our results have not ruled out the possibility that diethylstilboestrol in the rhesus monkey is 
embryotoxic, causing early embryonic death and abortion.
Histological evaluation of the vaginal and cervical mucosa in the female infant was 
unrewarding. In women exposed to diethylstilboestrol in utero non—neoplastic changes included 
cervical erosion and vaginal adenosis, the incidence of which is about 30% (Scully et al, 1974 ; 
Sherman et al, 1974). We do not know whether such non—neoplastic changes could be induced in 
female rhesus monkeys.
ABSTRACT
Diethyl stilboestrol was administered prenatally to a group of four pregnant rhesus monkeys from  
day 45 of gestation until parturition at a dose level of 1 mg/kg/day. Two treated monkeys aborted.
Two infant monkeys, one male and one female, were born after approximately 168 days of gestation, 
their mothers having received a total of 655 mg and 642 mg of diethyl stilboestrol respectively. Both 
infants were allowed a recovery period of 84 weeks before being killed. During the first 10—12 weeks 
of the recovery period, evidence of physiological stimulation of the sex skin was apparent. At post 
mortem examination the prostate and seminal vesicles of the male infant were found to be small 
although no histological abnormalities were apparent. The reproductive tract of the female infant was 
normal.
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C H A P T E R  T E N
THE INCIDENCE OF M A M M A RY TUM OURS




The value of the Beagle dog as a suitable animal model for the long-term  toxicological 
evaluation of oral contraceptives has been questioned (Hill and Dumas, 1974 ; Drill, 1975). Such 
prospective studies were introduced in order to determine the effects that might result in women 
from the long-term  usage of hormonal contraceptives, especially with regard to their carcinogenic 
potential (Berliner, 1974), Studies of seven years duration are mandatory in the United States of 
America, Sweden and Australia, while other countries, notably the United Kingdom, show great 
interest in whether such tests have been conducted. The spontaneous incidence of mammary tumours 
and dysplasias in the Beagle dog must be taken into account when assessing the results of these 
investigations and publication of such data has been encouraged (Owen and Briggs, 1976). The 
purpose of this study, therefore, is to record the spontaneous incidence of mammary tumours as 
determined by standard toxicological techniques using the International Histological Classification of 
Tumours of Domestic Animals (Hampe and Misdorp, 1974), in a group of 40 eight—year old 
nulliparous Beagle dogs.
M A TER IA LS AND METHODS
Forty pure bred Beagle bitches (Appleton strain) were housed individually from the age of 
4—5 months under standard laboratory conditions at the Huntingdon Research Centre. They were 
fed a fixed amount of a complete dry diet, and water was available ad libitum. The dogs were the 
subject of a carcinogenicity experiment of 7% years duration, details of which have been published 
(Heywood et al, 1977). Since treatment did not increase the incidence of mammary tumours, the 
data from both treated and control animals has been combined. Clinical examinations were made every 
six months, and just before the animals were killed. The animals were killed by injecting a lethal 
dose of pentobarbitone intravenously, and a detailed post mortem examination was immediately 
performed on each dog. The individual mammary glands on the left and right sides were dissected 
free as a unit with the attached covering skin. Representative sections of tissue were taken from all 
the major organs. These tissues, and any abnormalities detected on macroscopic examination were 
fixed in 10% buffered formalin for 4—8 weeks. After sections had been taken, through the teat, from  
each individual mammary gland, the tissues were processed in the usual way for microscopic 




The average age of the Beagle dogs was 8 years and 2 weeks (range 8 years to 8 years and 7 weeks). 
A total of 417 mammary glands were examined, an average of 10.4 mammary glands per dog. Five 
palpable abnormalities of the mammary gland were found on clinical examination. After macroscopic 
and histological evaluation two benign mammary tumours (Table 26), a papillary complex cyst 
(Table 27), a fibroma and an incarcerated inguinal hernia were identified. The peri—canalicular 
fibroadenoma (dog 928) and the papillary complex cyst were both detected when the dogs were 3 years 
of age. Over the 5—year observation period neither grew significantly. The papillary cystadenoma 
(dog 930) was detected when the dog was VA years of age.
Histological examination of each mammary gland revealed in addition to the tumours previously 
described three small benign mammary tumours (Table 26 ).These comprised an intracanalicular 
fibroadenoma (dog 928), a complex adenoma (dog 950) and a tubular adenoma (dog 950). A total of 
5 benign mammary tumours was therefore found in a total of 3 of the 40 dogs, making an incidence 
of 7.5%
Dysplasias of the mammary gland were more frequent (Table 27). In addition to the papillary 
complex cyst previously described, areas of nodular hyperplasia and foci of regular proliferation of 
epithelial cells in ducts or acini (epitheliosis) were found at histological examination. A total of 11 
areas of nodular hyperplasia was found in a total of 9 dogs, and foci of epitheliosis were seen in a 
total of 35 mammary glands in a total of 12 dogs.
DISCUSSION
There are many reports of the incidence of mammary tumours in dogs other than those 
maintained as laboratory animals, and these studies have recently been reviewed (Hamilton, 1974 ; 
Owen and Briggs, 1976). The difficulties of deriving and comparing such incidence rates (Hamilton, 
1974) and the difficulties of extrapolating such information to the laboratory Beagle dog (Taylor et al,
1976) have been outlined.
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TABLE 26
Tumours of the mammary gland encountered in individual dogs
Dog No. Tumour type
928 * Pericanalicular fibroadenoma
Intracanalicular fibroadenoma
930 * Papillary cystadenoma
950 Complex adenoma
Tubular adenoma
Detected at clinical examination
TABLE 27
Incidence of dysplasias of the mammary gland
Dysplasia Nos. of mammary glands 
affected
Nos. of dogs 
affected
* Papillary complex cyst 1 1
Areas of nodular hyperplasia 11 9
Foci of regular proliferation 
of epithelial cells in ducts 
or acini
35 12
Detected at clinical examination
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There are few reports of the incidence of spontaneous mammary neoplasia in laboratory dogs.
Age specific incidence rates for Beagle dogs have been derived from life-span studies (Andersen, 1965 ; 
Taylor et al, 1976), toxicological studies (Finkel and Berliner 1973 ; Owen and Briggs, 1976) and 
whole mount preparations of the mammary gland (Cameron and Faulkin, 1971 ; Warner, 1976). 
Andersen (1965) has stated that in a life-span study of 354 female Beagles clinical signs of mammary 
tumours had occurred in approximately 50% of these dogs by 6 to 8 years of age. Taylor et al (1976) 
have presented a more detailed account of the incidence of mammary neoplasia in the University of 
Utah Beagle dog colony. They reported that the incidence rate remained low through 7 years of age, 
and only 1 tumour was observed below the 5—year age class, a benign adenoma that appeared at 
1.6 years of age. A sharp increase in the incidence rate occurred at approximately 8 years of age and 
remained high thereafter. They also noted that the first cancer occurred at 7 years of age.
Wyeth International (Owen and Briggs, 1976) have examined tissues from 50 normal female 
Beagle dogs, used in a control study of 7 years duration. A  total of 36 mammary tumours were found 
in a total of 22 animals, 8 other animals showing areas of adenomatous hyperplasia within mammary 
tissue. All the tumours were benign, small in size and showed neither local invasion nor distant 
metastatisis. Finkel and Berliner (1973) stated that in studies conducted by Food and Drug 
Administration and manufacturers of oral contraceptives, spontaneous incidence of mammary tumours 
in control animals averaged about 12% between 5 and 6 years. They also noted that during such studies 
nodules 1 to 2 mm in diameter were palpable and therefore tabulated.
Cameron and Faulkin (1971 ) using a whole mount technique have described hyerplastic and 
inflammatory nodules, many of which were microscopic, in the mammary glands of four untreated Beagle 
dogs. The dogs were aged from 7.6 to 8.5 years of age at post mortem. These nodules were studied 
histologically and a total of 654 atypical glandular nodules were identified, 94 of which were 
considered neoplastic (14% of the total lesions). Further classification of the neoplasms is not given. 
Warner (1976) also using whole mount preparations examined 39 Beagle bitches 6 months to 4 years 
of age. Dysplastic lesions occurred at 2—3 years of age at which time more than 50% of the females 
had dysplasias. At 3—4 years of age, a total of 1,795 dysplasias were found in 12 bitches. These 
lesions were 1—4 mm in diameter and not clinically palpable.
There would appear to be considerable variation in age specific incidence rate of mammary 
neoplasia in the Beagle dog. Some of these discrepancies are undoubtedly due to the widely different 
techniques employed in deriving such data and due to the fact that an International Histological 
Classification of Tumours of Domestic Animals has only recently been available. However, from these 
observations, it may be concluded that (a) malignant mammary tumours are very uncommon in 
Beagle dogs aged 8 years of age ; (b) clinically palpable benign mammary tumours are present in only 
a small proportion of 8 year old dogs but this figure may be markedly increased by complete 
histological evaluation ; (c) dysplasias of the mammary gland, the majority of which are microscopical, 
are very frequent in dogs of eight years of age.
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ABSTRACT
The incidence of mammary neoplasia in a group of forty nulliparous 8 year old female Beagle 
dogs is described. The age specific incidence rates of mammary neoplasia in laboratory Beagle dogs 
are discussed.
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C O N C L U S IO N
: 114 ;
A. Oral Contraceptives and adverse drug reactions
(i) Oral contraceptives are used by 50 million women in developed and developing countries around
the world (Piowtrow and Lee, 1974), but only a few long-term  follow—up studies are currently in 
progress. In the U.K. 23,000 women are taking part in a Royal College of General Practitioners 
Study (Lancet, 1977) and 17,000 women are participating in the Oxford Family Planning Association 
Study (Vessey, et al., 1977). In these studies, "pill—takers" are considered as one group and no 
distinction is made between different oral contraceptive pills. Both groups of workers have found 
increased mortality from diseases of the circulatory system, confirming the results of retrospective 
studies.
Toxicity studies in non—human primates have failed to show any relationship between oestrogens 
and cardiovascular disease. The administration of ethinyl estradiol to rhesus monkeys at a dose rate 
of 0.050 mg/kg for 36 months (21 days on, 7 days off) produced no changes in the coagulation tests 
normally used in toxicity studies (Goldzieher and Kraemer, 1972). Cardiovascular disease was not 
encountered during a series of experiments with ethinyl estradiol (chapters 2—6). The 
administration of mestranol to rhesus monkeys for 84 months at a dosage rate of 0.1 mg/kg/day 
(21 days on, 7 days off) produced a mild decrease in haemoglobin and packed cell volume (Geil and 
Lamar, 1977). In a study in which ovariectomised baboons were given an atherogenic diet, treatment 
with ethinyl estradiol at doses equivalent to the human dose rate did not influence the development of 
atherosclerosis (McGill et al, 1977). Non—human primates would therefore appear to be unsuitable 
animal models for the investigation of the association between oestrogens and cardiovascular disease.
In contrast to non—human primates, the administration of oestrogens to the dog has been shown 
to cause marked changes in haemopoietic tissue, particularly bone marrow elements. Ethinyl 
estradiol at dosage levels of 5 mg/kg/day for up to 95 days produced an initial neutrophil leucocytosis 
followed by thrombocytopoenia, leucopoenia, haemorrhage and aplastic anaemia. (Capel—Edwards, 
et al 1971). A t a dose level of 1 mg/kg/day, ethinyl estradiol induced a neutrophil 
leucocytosis (chapter 1 ). The administration of mestranol to dogs for 77 months at a dose rate of 
0.05 mg/kg/day (21 days on, 7 days off) induced a mild decrease in packed cell volume and 
haemoglobin (Geil and Lamar, 1977). The mechanism of action of oestrogens on haemopoietic tissue 
in the dog is unknown (Chiu, 1974). The initial neutrophil leucocytosis is probably associated with 
the role of oestrogens in uterine defence during oestrus (Rowson, et al, 1953 ; Broome, et al, 1959). 
The thrombocytopoenia may possibly be associated with the diapedetic uterine bleeding which occurs 
during oestrus in the dog. These observations however, are not in keeping with the cardiovascular 
changes encountered in women.
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(ii) The relationship between oral contraceptives and the liver has recently been reviewed (Metreau,
et al, 1972), Both jaundice and changes in liver function tests have been reported in a small proportion 
of "pill—takers". The jaundice usually occurs during the first three months and is both cholestatic and 
cytolytic in origin. Raised SAP and serum transaminase levels are often noted in association with 
increased serum bilirubin. Histological examination shows intrahepatic cholestasis with canalicular and 
hepatocellular bile stasis. Minor ultrastructural abnormalities are observed, including dilatation of 
canaliculi, smooth endoplasmic reticulum and mitochondria. Changes in liver function tests are more 
frequent than jaundice and include bromosulphalein retention and raised SAP and transaminase levels. 
Raised transaminase levels may disappear even if treatment is continued, suggesting that hepatocyte 
adaptation has taken place. The histological appearance of the liver is almost always normal but 
ultrastructural changes can be seen similar to those observed during jaundice.
The administration of ethinyl estradiol to rhesus monkeys at dose levels of either 500 jug/kg/wk 
or 1 0 0 /ig/kg/day raised both LAP and SAIT levels. When dosing was discontinued these values fell to 
predose levels. The livers appeared to be normal histologically but ultrastructural changes were seen by 
means of transmission electron microscopy (chapters 2 and 3). No changes in liver enzyme values were 
observed when ethinyl estradiol was given to post partum lactating rhesus monkeys at similar dose rates 
suggesting that high levels of endogenous oestrogens during pregnancy may have altered the 
metabolism of ethinyl estradiol (chapter 5). These changes are similar in many respects to the changes 
in liver function tests noted in women using oral contraceptives and confirm that, as far as the liver is 
concerned, ethinyl estradiol is not highly cytolytic. However, the clinical, biochemical and 
morphological changes associated with jaundice were not evident nor was bile flow diminished 
(chapter 4). At dose rate of 0.050 mg/kg (21 days on, 7 days off) ethinyl estradiol did not change 
serum transaminase and isocitric dehydrogenase levels (Goldzieher and Kraemer, 1972). No changes 
consistent with liver dysfunction were observed when ethinyl estradiol was given to the dog at a dose 
level of 1 mg/kg/day (chapter 1). When ethinyl estradiol was given to female rats at a dose level of 
250/ig/kg, serum alkaline phosphatase levels were increased (Gopinath et al, 1978). No abnormalities 
were seen histologically in the liver and it was concluded that the increased levels were at least in part from  
new synthesis by the liver.
(iii) Epidemiological investigations have shown that the incidence of gall bladder disease in women
is increased by the use of oral contraceptives (Lancet, 1973). Other, more direct, evidence suggests 
that oral contraceptives produce changes in bile composition. Oral contraceptives have been shown to 
increase the cholesterol concentration of hepatic bile after cholecystectomy (Pertsemlidis, et al, 1974). 
A similar change was seen in gall bladder bile obtained by duodenal drainage from normal women 
(Bennion et al, 1976). Gall bladder bile was reported to be more saturated with cholesterol during 
contraceptive therapy than during the normal menstrual cycle and in addition, the proportion of 
chenodeoxycholic acid was reduced. Fundamental changes in bile composition, particularly in 
cholesterol solubility may therefore be a contributory factor in the aetiology of cholesterol gall­
stones that are usually found inthe gall bladder.
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While spontaneous gall—stones in non—human primates are comparatively rare (van der Linden 
and Bergman, 1977) cholesterol gall-stones have been reported in baboons (Glen and McSherry, 1970; 
McSherry et al, 1971 ). In addition, analysis of the gall bladder bile of the rhesus monkey has shown 
that rhesus monkeys secrete a bile similar in composition to that of man (Campbell et al, 1971).
Non—human primates have therefore been used to investigate the effects of ethinyl estradiol on bile 
flow and composition. Ethinyl estradiol caused a significant decrease in biliary cholesterol 
concentration in baboons subjected to cholecystopexy procedures,(Morissey et al, 1977), A decrease 
in both cholesterol concentration and secretion rate was observed in rhesus monkeys with an intact 
entero—hepatic circulation, but the relative molar concentrations were such that the overall cholesterol 
saturation index was unchanged (chapter 4), These observations are not in keeping with the effect of 
oral contraceptives on biliary cholesterol levels in women (Bennion et al. 1976). Furthermore, in the 
rhesus monkeys, bile salt concentrations decreased but the bile salt secretion rate was unchanged.
While the effects of oestrogens on flow and composition of bile in the dog has not been 
specifically investigated, an association between progestogens and changes in the gall bladder is well 
established. Long-term administration of progestogens may induce cystic mucinous hyperplasia of 
the gall bladder epithelium ( Mawdesley—Thomas and Noel, 1967 ; Nelson and Kelly, 1976). In 
some cases the accumulation of mucoid material is sufficient to occlude the gall bladder lumen almost 
completely (Geil and Lamar, 1977). The significance and pathogenesis of such lesions remains 
uncertain.
Alterations in bile flow and bromosulphthalein (BSP) clearance have been recorded in the rat 
by Kreek et al (1969), who reported that 0.5 mg of ethinyl estradiol per day given to female rats for 
nine days reduced bile flow by 50% compared with the controls and delayed the appearance of BSP in 
the bile. A similar decrease in bile flow was shown by Heikel and Lathe (1970), who also reported 
that mestranol reduced bilirubin excretion. Davis and Kern (1976) showed bile acid synthesis to 
decrease by 50% after five days of ethinyl estradiol treatment at 5 mg/kg/day; the ethinyl estradiol 
did not alter biliary cholesterol excretion, and the bile contained less bile acid in relation to 
cholesterol. The hepatic bile acid concentration was not increased by ethinyl estradiol treatment.
The impairment of bile flow in rats might be due to an increase in cannicular permeability or be 
secondary to an impairment of the system responsible for the secretion of the bile salt non—dependent 
fraction of canalicular bile water. The results of Gumucio and Valdivieso (1971 ) indicate that the bile 
salt non—dependent fraction in the rat was the canalicular bile water and that the inhibitory effect of 
ethinyl estradiol on bile flow was exerted on the water secreted by the hepatocytes. Forker (1969), 
working with estrone administered to 250 g rats at the dosage level of 2.5 mg for seven days, 
demonstrated increased permeability of the biliary tree, as determined by an increase in the biliary 
clearance of sucrose and mannitol. Estrone reduced the clearance of BSP. He concluded that oestrogen 
cholestasis might involve enhanced diffusion of materials from bile and blood, in addition to 
inhibiting active transportation in the opposite direction.
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Gallagher et al (1966), working with a variety of steroids including estradiol, estrone, stilbestrol 
and other synthetic steriod oestrogens, demonstrated impaired BSP metabolism in the rat ; this effect 
extended to other steroids derived from the in vivo metabolic transformation of estradiol in man.
In all rodent studies, jaundice has been absent from oestrogen induced cholestasis and this can 
probably be attributed to the low concentration of bilirubin and the high rate of bile flow  
characteristic to the rat.
(iv) Liver cell adenomas are rare in women. Recently a small but significant number of cases have
been reported in young women who had taken oral contraceptives. (Christopherson and Mays, 1977). 
Most of these women had taken oral contraceptives for more than five years and although, the 
tumours were benign, there was a 21% fatality rate (Matiboubi and Shubik, 1976).
The effect of long-term administration of ethinyl estradiol on the liver of both non—human 
primates and dogs has not been recorded. Carcinogenicity studies with ethinyl estradiol alone have 
been carried out in both rats and mice (Committee on Safety of Medicines, 1972). Ethinyl estradiol 
increased the incidence of benign liver cell tumours in both male and female rats and produced 
malignant liver cell tumours in female rats.
(v) Women who use oral contraceptives have an increased rate of referral to hospital for treatment of
cervical erosion (Royal College of General Practitions, 1974 ; Vessey et al, 1976). Whether oral 
contraceptives caused the erosions, or whether there was bias in diagnosis, is uncertain. While the 
gross anatomy of the cervical canal of the rhesus monkey is somewhat different from that of women 
(Davis and Schneider, 1975) the administration of ethinyl estradiol at a dose rate of 100 ^g/kg/day 
induces histological changes in the cervical epithelium (chapter 3). Graham (1970) has shown that the 
spread of stratified squamous epithelium throughout the endocervical canal following treatment with 
oestrogens is the result of stimulation of foci of squamous cells present at this site. In rhesus 
monkeys therefore the cervical epithelium is a "target" tissue for oestrogens. Significant cervical 
changes have not been recorded when oestrogens have been administered to dogs.
(vi) In a recent review of fertility regulating methods, Kessler and Standley (1977) raised the question
of whether hormonal contraceptives should be given to lactating women. Contraceptive steroids might 
affect the amount and composition of milk and might be transferred through the milk to the infant.
In developing countries lactation performance is particularly important, as failure of breast feeding may 
lead to infant malnutrition. Since the introduction of oral contraceptives, physicians have suspected an 
inhibitory effect on lactation but the results of published reports on this subject are conflicting 
(Chopra, 1972). When ethinyl estradiol (0.3 mg daily) was given to healthy nursing mothers for five 
days after birth, milk yield was not affected but a significant increase in protein content of the milk 
was observed (Toaff et al, 1969). Milk yield was similarly unaffected when ethinyl estradiol was given 
to lactating women at a dose rate of 0.05 mg/day for 1 week (Borglin and Sandholm 1971).
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A preliminary study on the effects of ethinyl estradiol given at a dose rate of 100 /ig/kg/day to 
post partum lactating rhesus monkeys showed that ethinyl estradiol was secreted in the milk but at levels 
which were below the limits of detection of our assay methods. In addition, ethinyl estradiol did not 
appear to suppress established lactation (chapter 5). Physiological changes such as stimulation of the 
sex skin and mammary development were induced in the infants of mothers dosed with ethinyl 
estradiol, the toxicity of this compound in neonatal rhesus monkeys was therefore studied (chapter 6). 
At a dose rate of 100 ;^g/kg/day, the oral toxicity of ethinyl estradiol to neonatal rhesus monkeys 
was essentially similar to that observed in the adult rhesus monkey. Considering the low dosage 
levels present in oral contraceptives, the transfer of ethinyl estradiol through milk would not appear 
to constitute a major health problem.
(vii) Both retrospective and prospective epidemiological studies have shown that the use of oral
contraceptives is negatively associated with the appearance of benign lesions of the breast (Vessey, 
et al, 1972, Lancet, 1973 ; Vessey, et al, 1975 ; Vessey et al, 1976). When contraceptive steroids had 
been taken during the year prior to the diagnosis of breast cancer, the prognosis was not worsened 
(Spencer, et al, 1978). The results of such studies are reassuring but as most human carcinogens do not 
produce an effect until at least 10—15 years have elapsed from the time of exposure, final conclusions 
cannot be drawn (British Medical Journal, 1976a).
The requirement for the long-term  administration of contraceptive steroids to Beagle dogs 
and rhesus monkeys was initiated in 1967 following the report of mammary nodule induction in dogs 
and monkeys by the progestogen ethynerone (Finkel and Berliner, 1973). Screening of all 
contraceptive steroids for carcinogenic potential, particularly as regards the mammary gland, became 
mandatory in such countries as the U.S.A. and Sweden. Finkel and Berliner (1973) reported that 
ethinyl estradiol when given to Beagle dogs at dose rates up to 25 jug/kg/day for five years did not 
influence the development of nodules in the mammary gland. Unfortunately, no further details are 
given. Geil and Lamar (1977) recorded that when mestranol was administered to Beagle dogs at a 
dosage of up to 0.05 mg/kg/day for 77 months, no more mammary nodules were observed than in 
control dogs. They also noted that when mestranol was given to rhesus monkeys at a dosage level of up, 
to 0.1 mg/kg/day for 84 months there was no increase in mammary nodules. It would, therefore, 
appear that neither ethinyl estradiol nor mestranol influence the development of mammary nodules in 
these species. In contrast, certain progestational compounds have a marked tumorgenic effect on the 
mammary gland of Beagle dogs (Finkel and Berliner, 1973 ; Geil and Lamar, 1977 ; Weikel and Nelson,
1977). Whether this is a species—specific response is uncertain. The spontaneous incidence of mammary 
tumours and dysplasias in the Beagle dog must be taken into account when assessing these investigations. 
Owen and Briggs (1976) have encouraged the publication of such data (chapter 10). Clinically 
palpable nodules are normally present in only a small proportion of Beagle dogs under 8 years of age 
but sub-gross pathological examination may show that there are a large number of dysplastic lesions in 
both the Beagle dog (Cameron and Faulkin, 1971) and the human breast (Wellings et al, 1975).
: 119 :
Carcinogenicity tests with ethinyl estradiol alone have been carried out in both mice and rats. 
Ethinyl estradiol increased the incidence of malignant mammary tumours in both male and female 
mice, but it was suggested that the strain of mice may have influenced the results (Committee on 
Safety of Medicines, 1972). Drfll (1974) found that when either mestranol or ethinyl estradiol was 
given to male and female mice, the incidence of malignant mammary tumours was not affected'. 
McKinney et al (1968) reported that the administration of ethinyl estradiol alone to rats for 104 weeks 
at a dose rate of 53 jug/kg/day did not increase the incidence of tumours in any tissues. A slight 
increase in malignant mammary tumours was recorded in both male and female rats by the Committee 
on Safety of Medicine (1972) following the administration of ethinyl estradiol alone . Drill (1974) 
reported that the treatment of rats with the oestrogens estradiol, estrone, ethinyl estradiol and 
mestranol did at times increase the incidence of mammary adenocarcinoma in rats. While this data 
should not be interpreted directly in terms of human risk, at the levels of human exposure no obvious 
health hazards are apparent.
(viii) The possibility that antenatal exposure to contraceptive steroids may be associated with
meningomyelocele or hydrocephalus (Gal, et al, 1967), congenital limb reduction defects (Janerich, 
et al, 1974)., cardiovascular birth defects (Levy, et al, 1973 ; Heinonen et al, 1977), Di George 
syndrome (Nora and Nora, 1973) or complex combinations of defects (Nora and Nora, 1975) has been 
recorded. Other studies (Smithells, 1965 ; Oakley, et al 1973 ; Mulvihill, et al, 1974 ; Yasuda and 
Miller, 1975) have revealed no suggestion of teratogenic action. Preparations taken during the 
teratogenic period include oral contraceptives, pregnancy test drugs and post—coital contraceptives.
There seem to be few published accounts of the experimental administration of oestrogens to 
non—human primates during the teratogenic period. A preliminary investigation with ethinyl 
estradiol when given to rhesus monkeys at a dose level of 50 jug/kg/day during the teratogenic period 
failed to show any teratogenic effect (chapter 7). Further work, not only with ethinyl estradiol, but 
also with other contraceptive steroids is required but may be hampered by the evidence that, at high 
dosage levels, oestrogens may cause early embryonic death and abortion.
B. Hormone Replacement Therapy and Endometrial Carcinoma
A possible association between oestrogens and endometrial carcinoma in women has long 
been suspected. These suspicions have been founded on sporadic examples of endometrial carcinoma 
that seem to be related to endogenous or exogenous oestrogens, and on epidemiological studies showing 
an apparent association between oestrogens used for hormone replacement therapy and endometrial 
cancer. (Ryan, 1975 ; Lancet, 1977).
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Spontaneous tumours of the uterus are rare both in dogs and in non—human primates (Cotchin 
and Marchant, 1977). In addition, the long-term  administration of oestrogens to these species has 
failed to induce endometrial carcinoma. Dogs and non—human primates do not seem to be suitable 
animal models for the induction of endometrial carcinomas by oestrogens. However, certain oestrogens, 
particularly diethylstilboestrol, are capable of inducing tumour—like hyperplasia of both the genital 
and non—genital serosa both in dogs {Mawdesley—Thomas and Sortwell, 1968 ; O'Shea and Jabara, 
1971) and non—human primates (McClure and Graham, 1973) which in certain circumstances are 
indistinguishable from mesotheliomas. Ethinyl estradiol may also induce focal papilliform 
proliferation of the genital serosa but the extent and degree of this change is considerably less than with 
other oestrogens (chapter 1) and probably is of little toxicological significance.
The administration of ethinyl estradiol to mice produced malignant tumours of the uterine fundus 
and cervix in the high dosage group (Committee on Safety of Medicines, 1972) but no effects were 
apparent when ethinyl estradiol was given to rats (McKinney et al., 1968 ; Committee on Safety of 
Medicines, 1972). The fact that oestrogens may induce tumours of the uterus and cervix in mice has 
long been established. Cotchin and Marchant (1977) observed that the age at which experimental 
treatment begins is of importance and that as oestrogen administration leads to many untoward side 
effects, many animals die before such tumours may develop.
C. Prenatal exposure to diethylstilboestrol
An association between treatment of mothers with diethylstilboestrol for various 
complications of pregnancy and the development of vaginal and cervical adenocarcinomas in the 
female offspring has been well established. (Herbst and Scully, 1970 ; Herbst, et al, 1971 ;
Herbst et al, 1974). Non—neoplastic changes also found in female offspring include 
cervical erosion and vaginal adenosis (Scully, et al, 1974 ; Sherman et al, 1974 ; StafI and 
Mattingly, 1974 ; Herbst et al, 1975). Recently, adverse effects have also been found in male
offspring (Bibbo et al, 1975 ; Bibbo et al, 1977). In contrast to these observations a 25—year 
fo llo w -u p  study of the mothers exposed to diethylstilboestrol showed no increase in disease of the 
breast, uterus or ovary or other reproductive tract abnormality. (Bibbo et al, 1978).
Prenatal exposure of rhesus monkeys to diethylstilboestrol partially inhibits the normal 
development of the accessory sex glands of the male offspring (chapter 9). Abnormalities of the 
male reproductive tract have been reported in rats (Greene, et al, 1940), hamsters (Rustia 
and Shubik, 1976) and mice (Me Lachlan et al, 1975 ; Nomura and Kanzaki, 1977) following prenatal 
administration of diethylstilboestrol. Whether non—neoplastic changes can be Induced in the 
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Erythrocyte sedimentation rate (ESR) Wintrobe mm/1 hour
Packed cell volume (PCV) Estimated by Technicon 
SMA4A or Hawksley Micro 
Centrifuge
Haemoglobin (Hb) Estimated by Technicon 




Red cell count (RBC) Estimated by Technicon 
SMA4A
mill/cmm
Reticulocyte count (Reties) Brilliant cresyl blue and new 
methylene blue
red cells
Mean corpuscular haemoglobin 
concentration (MCHC)
MCHC = Hb (g%) x 100 
PCV (% red cells)
Mean cell volume (MCV) MCV = PCV (% red cells) x 10 cubic microns
RBC (mill/cmm)
Total white cell count (WBC) Estimated by Technicon SMA4A  
or Coulter ZF
1000/cmm
Platelet count Coulter Thrombo—Counter—C 1000/cmm
Prothrombin index (PTI) Quick's one—stage method 
(using Simplastin)




Plasma urea Technicon Autoanalyser method mg/100 ml (mg%) 
N 1—C (diacetyl monoxime)




Total serum proteins Technicon Autoanalyser method g/100 ml (g%) 
(Biuret)
Differential serum proteins Electrophoretic breakdown of g/100 ml (g%)
albumin a1, a2, i3 and y globulins 








Serum alanine aminotransferase 
(SAIT)
LKB 8600 Reaction Rate Analyser. mU/ml 
Diamed Test Kit.
Serum aspartate aminotransferase 
(SAsT)
LKB 8600 Reaction Rate Analyser. mU/ml 
Diamed Test Kit.
Serum leucine ami no peptidase Sigma Technical Bulletin 251 Goldberg and 
Rutenberg (GR) 
units
Serum Bilirubin Method of Malloy, H.T. and 
Evelyn, K.A. (J. biol, Chem. 1937, 
119, p.480) as modified by 
H. Vanden Bossche (Clinica Chim. 










Specific gravity Pycnometer or refractomer against protein 
standards.
pH pH meter









Clinitest (Ames Co.) 
Clinistix (Ames Co.) 
Acetest (Ames Co.) 
Ictotest (Ames Co.) 
Urobilistix
Haemoglobin Haemastix (Ames Co.)
Microscopically for sediment Centrifuged at 3000 rpm for 10 minutes
Histology
Stain Method
Harris's Haematoxylin and eosin "Histological Laboratory Methods" by B.D. Disbrey 
and J.H. Rack Livingstone Edinburgh & London 1970. 
p. 9 9 -1 0 1 .
Oil Red O "Histological Demonstration Techniques" by H.C. Cook 






Cholesterol saturation index (CSI)
"Methods of Biochemical Analysis" by P. Talaylay. 
Interscience. New York.
Method of Fiske, C.H. and Subbalow, Y.
(J. Biol. Chem., 1924, 6 6 , 3 7 5 -4 0 0 ).
Technicon Methodology AA 11—24.
0 2 1  _ bile salt/cholesterol found x 1 0 0
bile salt/cholesterol at saturation
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Expected Values for Dogs
IN VESTIG A TIO N RANGE UNITS
Haematology
ESR 0 -  5 mm/hour.
PCV 3 5 -  60 %
Hb 1 0 -  19 g%
RBC 4 -  7.5 mill/cmm
WBC 6 . 0 -  25.0 1000/cmm
Reticulocytes <2.0 %
Platelets 1 5 0 - 4 5 0 1000/cmm
Prothrombin Index 8 5 - 1 1 0 %
MCV 7 0 - 1 0 0 CU.JU
MCHC 2 7 -  35 %
Biochemistry
Urea 1 3 -  50 mg%
Glucose 8 0 - 1 1 6 mg%
Total Protein 4.5 -  6.8 g%
SAP 6 - 3 5 KA units
SAsT 2 0 -  60 mU/ml
SAIT 1 5 -  58 mU/ml
Sodium 1 3 5 -  155 mEq/l
Bilirubin 0.1 -  0.3 mg%
Urinalysis
pH 5 . 5 -  7.5
SG > 1035
Protein > 100 mg%
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Expected Values for Rhesus Monkeys
IN VESTIG A TIO N RANGE UNITS
Haematology
PCV 3 9 -  51 %
Hb 11.1 -  15.8 g%
RBC 4 . 5 -  6.6 mill/cmm
MCHC 2 5 -  30 %
MCV 6 9 -  93 cubic microns
WBC 3 . 4 -  22.2 1000/cmm
Neutrophils 0 -  11.4 1000/cmm
Lymphocytes 0 . 6 -  13.4 1000/cmm
Platelet count 1 9 0 - 5 1 0 1000/cmm
Prothrombin index 9 2 - 1 0 7 %
Biochemistry
Urea 21 -  50 mg%
Glucose 6 4 - 1 1 4 mg%
Total protein 6.8 -  8.5 g%
AI bumin 3.5 -  5.4 g%
a1 globulin 0.1 -  0.5 g%
a2 globulin 0.2 -  1.0 g%
|3 globulin 0 . 9 -  2.1 g%
y  globulin 0 -  1.6 g%
SAP 3 3 -  144 KA Units
SAIT 0 — 58 mU/ml
SAsT 9 - 5 6 mU/ml
LAP 93 -  343 GR units
Sodium 1 3 6 - 1 5 9 mEq/l
Potassium 3.4 -  5.4 mEq/l
Urinalysis
pH 6.7 -  9.1 -
Volume 0 - 6 9 ml
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SUMMARY
Administration of ethinyl estradiol to the female rhesus monkey at a 
dosage level of 100 jug/kg/day for 26 weeks resulted in elevation of serum 
alanine aminotransferase (SALT) and LAP values. Light microscopy showed 
no morphological change, but by electron microscopy hepatocytes could 
be identified containing needle-shaped electronlucent areas in two out of 
four treated animals only, one of which had periportal hepatocytes with 
intracisternal sequestration of the endoplasmic reticulum.
INTRODUCTION
During the course of a preliminary study on the effect of ethinyl estradiol 
on the rhesus monkey, Wadsworth and Heywood [7] commented on a rise 
in liver enzyme values without histological change in the liver. It was decided 
to make further investigations with particular reference to hepatocyte mor­
phology by electron microscopy.
MATERIALS AND METHODS
Ethinyl estradiol was administered daily to four young female rhesus 
monkeys at the dose level of 100 jug/kg. Two monkeys acted as undosed 
controls. Clinical signs, body weight and food consumption were monitored 
throughout the course of the study. Haematological investigations and bio­
chemical tests, comprising estimation of plasma urea and glucose, serum 
protein (total and differential), serum alkaline phosphatase, serum alanine
Abbreviation: SALT, serum alanine aminotransferase.
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aminotransferase, serum leucine aminopeptidase, serum bilirubin, sodium 
and potassium, were carried out before the start of dosing and after 6, 12 
and 24 weeks’ dosing. On completion of the study, the animals were killed 
and immediately afterwards a full macroscopic examination was made, 
during which the major organs were weighed and tissues preserved in 10% 
buffered formalin for subsequent sectioning and histological examination. In 
addition, liver samples were fixed in 4% glutaraldehyde buffered with 0.05 M 
cacodylate to pH 7.3 at 4°C. Three 1 mm^ blocks of tissue from each animal 
were post-fixed in 1% osmium tetroxide buffered with 0.5 M cacodylate to 
pH 7.3, dehydrated in alcohol and embedded in epoxy resin. 1 jum survey 
sections were cut and stained with 1% toluidine blue for examination with 
the light microscope. Silver/gold ultra-thin sections of representative areas 
were mounted on copper grids and subsequently stained with lead citrate 
and uranyl acetate. These sections were examined using Philips EM 300 
operating at 60 kV. Selected areas were photographed on Kodak Fine Grain 
Positive 35 mm film and enlarged as necessary.
RESULTS
Development of the sex skin, together with vulval enlargement was seen in 
the four treated animals from the second week of dosing. The folding of the 
sex skin was progressive and towards the end of the dosing period extended 
over the lumbar region. There was suppression of menstruation in the dosed 
animals, whereas in the undosed controls menstruation, although not follow­
ing a regular pattern, was obvious throughout the experimental period. Body 
weight and food consumption were not affected. No significant haematolog- 
ical changes were detected. There was an increase in SALT and LAP values 
(Table 1).
Post-mortem examination after 26 weeks’ dosing showed the ovaries of 
the treated monkeys to be small and inactive, whereas in the two control 
animals the ovaries were enlarged and either mature graafian follicles or cor­
pora lutea were evident. The treated animals showed bilateral enlargement 
and congestion of the fimbrium of the fallopian tubes. However, the degree 
of enlargement was no greater than that encountered in the untreated con­
trol monkeys with normal menstrual cycles. The results of the organ weight 
analysis showed the absolute and relative weights to be within our accepted 
normal range.
At histological examination, the morphological appearance of the livers of 
treated animals was essentially similar to that in the two control animals. In 
the ovaries of the treated animals, only small secondary follicles were appar­
ent, whereas both corpora lutea and mature graafian follicles were evident in 
the control monkeys. The fimbrial epithelium of the fallopian tubes in the 
treated monkeys showed bilateral hyperplasia. In the uteri of the treated 
animals, slight dilatation of endometrial glands could sometimes be seen.
In the cervix, sporadic small areas of squamous epithelium were observed,
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TABLE I
GROUP MEAN SALT VALUES (mU/ml) AND LAP VALUES (G.R. UNITS)
Group Parameter Dose week
0 6 12 24
Control SALT 26 50 30 24
LAP 119 182 238 179
Ethinyl estradiol SALT 30 110 100 74
100 Mg/kg/day LAP 288 524 551 500
whereas in the control animals only columnar epithelium was noted. The 
vaginal epithelium of treated animals was several cells thick and heavily 
comified.
By electron microscopy, needle-shaped electronlucent areas, which were 
sometimes bounded by a membrane were seen in a few hepatocytes (Fig. 1). 
This change was apparent in two of the treated animals. In addition, in one 
of these affected animals, some hepatocytes (mainly periportal) showed 
intracisternal sequestration of the rough endoplasmic reticulum (see Fig. 2). 
No morphological abnormalities were detected in the livers of the other two 
treated animals.
DISCUSSION
The results of this study confirm the previous observation by Wadsworth 
and Hey wood [7] that ethinyl estradiol causes an increase in SALT and LAP 
values. Elevation of these enzyme levels had, in the past, been taken as an 
indication of liver dysfunction. Pathological changes could not be seen by 
light microscopy in the livers of treated animals, although ultrastructural 
abnormalities were detected by means of transmission electron microscopy 
in two of the four treated animals. The* changes found in the hepatocytes 
were not considered to be sufficient to account for the increased SALT and 
LAP values. The needle-shaped electronlucent areas seen in the cytoplasm of 
the few hepatocytes in these two animals could possibly represent a cleft 
remaining after a crystal had been lysed out during processing. Crystalline 
mitochondrial inclusions have been recorded in women on steroid therapy 
[4 ]. While no definite evidence exists that crystals were present in this 
study, or that they were mitochondrial in origin, these cytoplasmic clefts 
were not apparent in the control animals and were considered to be related 
to the administration of the ethinyl estradiol. Ghidoni [2] also noted these 
cleft-like spaces in irradiated monkey hepatocytes, but could not determine 
their origin, or relate them to loss of material during processing.
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Fig. 1. Hepatocyte containing cytoplasmic “clefts” adjacent to smooth endoplasmic 
reticulum and microbodies. X 22 000.
Intracisternal sequestration was noted in one of the four treated animals. 
This term is used to describe a pattern of organisation of the rough endo­
plasmic reticulum where vesicular profiles of the latter are seen lying within 
dilated cisternae. It is thought that the primary stage of this process is the 
formation of papillary processes from the wall of a dilated cistern. Later, 
such processes may be pinched off to form vesicular structures which come 
to lie free within the cisternae. The formation of papillary projections from 
ductal and surface epithelia has been linked with proliferative processes and 
it could be that this phenomenon, noted in our study, is a similar process 
and that it reflects a type of hypertrophy of the rough endoplasmic reti­
culum. This probably represents an increase in metabolic activity caused by 
the administration of ethinyl estradiol.
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The other changes observed involved the sex skin, ovaries, fallopian tubes, 
uterus, cervix and vagina. In the uterus, cystic dilatation of the endometrial 
glands has been recorded by Geschickter and Hartman [1] and McClure and 
Graham [5]. Overholser and Allen [6] first recorded squamous metaplasia 
in the cervix following estrogen administration. Studies by Graham [3] have 
shown that this spread of stratified squamous epithelium throughout the 
endocervical canal is the result of stimulation of small foci of squamous 
cells occurring naturally at this site, putting paid to the notion that the 
squamous epithelium arises by metaplasia of columnar cells.
Fig. 2. Hepatocyte showing intracisternal sequestration of granular endoplasmic reti­
culum. X 22 000.
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SUMMARY
The incidence of mammary neoplasia in a group of 40 nulliparous 8-year-old 
female Beagle dogs is described. The age-specific incidence rates of mammary 
neoplasia in laboratory Beagle dogs shows considerable variation: malignant 
mammary tumours are very uncommon in 8-year-old Beagles; clinically palpable 
benign mammary tumours are present in only a small proportion of these dogs, 
but more are seen on histological examination; mammary gland dysplasias, 
although normally detectable only by microscopy, are prevalent in 8-year-old 
dogs.
INTRODUCTION
The value of the Beagle dog as a suitable animal model for the long-term 
toxicological evaluation of oral contraceptives has been questioned [4,9]. 
Prospective studies of this type were introduced in order to determine the 
possible effects in women of the long-term use of hormonal contraceptives, 
especially with regard to their carcinogenic potential [2 ]. Studies of 7 years’ 
duration are mandatory in the United States of America, Sweden and 
Australia, while authorities in other countries, notably the United Kingdom, 
show great interest in whether such tests have been conducted. The 
spontaneous incidence of mammary tumours and dysplasias in the Beagle 
dog must be taken into account when assessing the results of these investigations, 
and publication of such data has been encouraged [10]. The purpose of this 
paper, therefore, is to record the spontaneous incidence of mammary tumours 
described by standard toxicological techniques using the International 
Histological Classification of Tumours of Domestic Animals [7 ], in a group 
of 40 8-year-old nulliparous Beagle dogs.
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MATERIALS AND METHODS
40 pure-bred Beagle bitches (Appleton strain) were housed individually from 
the age of 4—5 months under standard laboratory conditions at the Huntingdon 
Research Centre. They were given a standard amount of a complete dry diet, 
and water was available ad libitum. The dogs were used in a carcinogenicity 
experiment of 7.5 years’ duration, details of which have been published [8]. 
Table I presents the dosage groups, together with the findings. As the treatment 
did not increase the incidence of mammary tumours, the data from both 
treated and control animals have been combined. Clinical examinations were 
made every 6 months, and the animals were killed by intravenous injection of 
pentobarbitone: a detailed post-mortem examination was immediately performed 
on each dog. The individual mammary glands on the left and right sides were 
dissected free as a unit with the attached covering skin. Representative sections 
of tissue were taken from all major organs. These tissues, and any abnormalities 
detected on macroscopic examination, were fixed in 10% buffered formalin for 
4—8 weeks. After sections had been taken through the teat from each individual 
mammary gland, the tissues were processed in the usual way for microscopic 
examination by embedding in paraffin wax (M.P. 56°C), sectioning at 5 Aim and 
staining with haematoxylin and eosin.
TABLE I












toothpaste — — -  8
15 mg/kg/day 928 + Pericanalicular fibroadenoma
chloroform in 928 — Intracanalicular fibroadenoma 8
toothpaste 930 + Papillary cystadenoma
Vehicle 950 — Tubular adenoma 
Complex adenomacontrol 950 —
Alternative 
non chloroform 
toothpaste — ____ -  7
Undosed control — — -  5
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RESULTS
The average age of the Beagle dogs was 8 years and 2 weeks (range 8 years 
to 8 years and 7 weeks). A total of 417 mammary glands was examined, an 
average of 10.4 per dog. Four palpable abnormalities of the mammary gland 
were found on clinical examination. After macroscopic and histological 
evaluation two benign mammary tumours, a pericanalicular fibroadenoma 
and a papillary cystadenoma (Table I), a papillary complex cyst (Table II) and 
a fibroma were identified. The pericanalicular fibroadenoma (dog 928) and 
the papillary complex cyst were both detected when the dogs were 3 years of 
age. Over the subsequent 5-year observation period neither grew significantly. 
The papillary cystadenoma (dog 930) was detected when the dog was 7,5 years 
of age.
Histological examination of each mammary gland showed, in addition to the 
palpable tumours previously described, three small benign mammary tumours 
(Table I). These consisted of an intracanalicular fibroadenoma (dog 928), a 
complex adenoma (dog 950) and a tubular adenoma (dog 950). Five benign 
mammary tumours were therefore found in three of the 40 dogs, an incidence 
of 7.5%.
Dysplasias of the mammary gland were more frequent (Table II). In addition 
to the papillary complex cyst previously described, areas of nodular hyperplasia 
and foci of regular proliferation of epithelial cells in ducts or acini (epitheliosis) 
were found on histological examination. Eleven areas of nodular hyperplasia 
were found in nine dogs altogether, and foci of epitheliosis were seen in 35 
mammary glands in 12 dogs in all.
TABLE II
INCIDENCE OF DYSPLASIAS OF THE MAMMARY GLAND
Dysplasia Number of mammary 
glands affected
Number of dogs 
affected
Papillary complex cyst^ 1 1
Areas of nodular hyperplasia 11 9
Foci of regular proliferation of 
epithelial cells in ducts or acini 35 12
^Detected at clinical examination.
DISCUSSION
There are many reports of the incidence of mammary tumours in dogs 
other than those maintained as laboratory animals, and these studies have
2 8 8
recently been reviewed [6,10]. The difficulties of deriving and comparing 
such incidence rates [6] and the difficulties of extrapolating such information 
to the laboratory Beagle dog [11] have been outlined.
There are few reports of the incidence of spontaneous mammary neoplasia 
in laboratory dogs. Age-specific incidence rates for Beagle dogs have been 
derived from life-span studies [1,11], toxicological studies [5,10] and whole- 
mount preparations of the mammary gland [3,12]. Anderson [1] has stated 
that, in a life-span study of 354 female Beagles, clinical signs of mammary 
tumours had occurred in approximately 50% of these dogs by 6—8 years of 
age. Taylor et al. [11] have presented a more detailed account of the incidence 
of mammary neoplasia in the University of Utah Beagle dog colony. They 
reported that the incidence rate remained low through 7 years of age, and 
only one tumour was observed below the 5-year age class, a benign adenoma 
that appeared at 1.6 years of age. A sharp increase in the incidence rate 
occurred at approximately 8 years of age and remained high thereafter. They 
also noted that the first cancer occurred at 7 years of age. Scientists at Wyeth 
International [10] have examined tissues from 50 normal female Beagle dogs, 
used in a control study of 7 years’ duration. A total of 36 mammary tumours 
was found in 22 animals, 8 other animals showing areas of adenomatous hyper­
plasia within mammary tissue. All the tumours were benign, small and showed 
neither local invasion nor distant metastasis. Finkel and Berliner [5] stated 
that, in studies conducted by the Food and Drug Administration and 
manufacturers of oral contraceptives, the average spontaneous incidence of 
mammary tumours in control animals was about 12% between 5 and 6 years. 
They also noted that, during such studies, nodules 1—2 mm in diameter were 
palpable and were therefore included in their statistics. Cameron and Faulkin 
[3 ], using a whole-mount technique for mammary glands described hyper­
plastic and inflammatory nodules, many of which were seen only under the 
microscope, in the mammary glands of untreated Beagle dogs which were 
7.6—8.5 years old at post-mortem examination. These nodules were studied 
histologically and a total of 654 atypical glandular nodules was identified,
94 of which were considered to be neoplastic (14% of the total lesions). Further 
classification of the neoplasia was not given. Warner [12], also using whole- 
mount preparations, examined 39 Beagle bitches aged 6 months to 4 years. 
Dysplastic lesions occurred at 2—3 years of age at which time more than 50% 
of the females had dysplasias. At 3—4 years of age, a total of 1795 dysplasias 
was found in 12 bitches. These lesions were 1—4 mm in diameter and not 
clinically palpable.
There would appear to be considerable variation in the age-specific incidence 
rate of mammary neoplasia in the Beagle dog. Some of these discrepancies 
are undoubtedly attributable to the widely different techniques employed 
in deriving such data and also to the fact that an International Histological 
Classification of Tumours of Domestic Animals has only recently been 
available. However, from these observations in this present study, it may be 
concluded that (a) malignant mammary tumours are uncommon in Beagle
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dogs aged 8 years; (b) clinically palpable benign mammary tumours are 
present in only a small proportion of 8-year-old dogs, but this figure may be 
markedly increased by complete histological evaluation; (c) dysplasias of 
the mammary gland, the majority of which are detectable only by microscopy, 
are very frequent in 8-year-old dogs.
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SUMMARY
The administration of ethinyl oestradiol to lactating rhesus monkeys had 
little effect on lactation. Physiological change characterised by stimulation of 
the sex skin and development of the mammary gland was induced in the 
infants suckled by the dosed mothers, although ethinyl oestradiol was not 
detected in the milk or serum of any of the infants.
INTRODUCTION
In a recent review of fertility-regulating methods, Kessler and Standley [3] 
raised the question of whether hormonal contraceptives should be given to 
lactating women. Contraceptive steroids might affect the amount and com­
position of the milk and might be transferred through the milk to the infant. 
Subhuman primates have not been used to investigate this problem, the only 
reference being that of Baghat et al. [1], who investigated the effects of 
19-nortestosterone in lactating rhesus monkeys. This paper reports a prelim­
inary study on the effects of ethinyl oestradiol in post partum lactating rhesus 
monkeys.
MATERIALS AND METHODS
Two post partum rhesus monkeys were allocated to receive 100 jug/kg/day 
of ethinyl oestradiol by gavage from day 5 post partum for 12 weeks. A further 
pair of post partum animals was undosed and acted as controls. The mothers 
were fed a complete dry diet, supplemented by fresh fruit and wholemeal 
bread. The body weights of the mothers and infants were recorded at weekly 
intervals.
Blood and milk samples were collected from the mothers, and blood sam­
ples were collected from the infants, at weekly intervals. To facilitate the 
collection of milk, 5 i.u. oxytocin was given i.v. immediately before collection. 
Abbreviations: LAP, leucine aminopeptidase; SAIT, serum alanine transaminase.
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The blood samples collected after 1, 3, 5, 7, 9 and 11 weeks were assayed 
for SAIT and LAP. Ethinyl oestradiol in the milk and blood samples collected 
after 4, 8 and 12 weeks’ dosing was estimated by radioimmunoassay, using 
the method described by Warren and Fotherby [5].
On completion of the dosing period the infant monkeys were killed and 
immediately afterwards subjected to full macroscopic examination, during 
which the brain, pituitary, heart, lungs, liver, spleen, pancreas, thymus, 
prostate, uterus, kidneys, thyroids, adrenals, gonads and seminal vesicles were 
removed and weighed. Small portions of these tissues, together with aorta, 
trachea, lymph nodes, gall bladder, urinary bladder, salivary gland, tongue, 
oesophagus, stomach, duodenum, jejunum, ileum, caecum, colon, skin, skeletal 
muscle, sciatic nerve, eye, vagina and vulva, together with any macroscopic 
abnormality, were placed in 10% buffered formalin fixative. The tissues were 
routinely processed in paraffin wax, sectioned at 5 jum and stained with 
haematoxylin and eosin. Additional pieces of liver and kidney were placed in 
formol calcium, sectioned at 12 jum and stained for fat with Oil Red O.
The mothers were maintained for a further 12 weeks’ observation period.
RESULTS
The male infant suckled by the female dosed with ethinyl oestradiol showed 
slight reddening of the perineum from week 3 of dosing. By week 9 there was 
considerable reddening and oedema and mammary gland enlargement was 
occurring. This persisted until the animal was killed at week 12. The female 
infant suckled by the mother dosed with ethinyl oestradiol showed slight 
reddening of the perineum during weeks 5, 7 and 8. The perineum and the 
mammary glands of the untreated control infants were unaffected.
The body weights of the infant monkeys and their mothers are presented 
graphically (Figs. lA  and B). The small number of animals used precludes 
definite conclusions, but there is some indication that the infants suckled by 
the dams receiving 100 /i g ethinyl oestradiol/day showed slower growth rates 
after 4 weeks’ dosing than did the control infants. The administration of 
ethinyl oestradiol to the mothers caused a loss of body weight.
The results of the SAIT and LAP values show that the administration of 
ethinyl oestradiol to  lactating rhesus monkeys failed to induce any changes in 
these liver enzymes (Fig. 2). Similarly, the liver enzymes of the infants were 
unaffected.
In the conjugated fragments of plasma, ethinyl oestradiol was detected 
after 4, 8 and 12 weeks’ dosing in one adult female monkey only. The values 
were 400, 200 and 130 pg/ml respectively. Ethinyl oestradiol was not detected 
in any of the milk samples, a lth o u ^  the lower level of sensitivity in this in­
stance was about 200 pg/ml.
At post-mortem examination the mammary glands of the male infant 
suckled by the female dosed with ethinyl oestradiol were prominent and the 














D o s in g  p e r i o d  ( w e e k s )
Fig.l. Body weights of infant (A) and adult (B) monkeys, 
ethinyl oestradiol.











D o s i n g  p e r i o d  ( w e e k s )
Fig.2. SAIT (mU/ml) rhesus monkeys dosed with ethinyl oestradiol. —  , non-lactating
female dosed with 100 ^g/kg/day; , lactating females dosed with 100 Mg/kg/day;
 , lactating female controls.
mediaposteriorly to the knee, anteriodorsally to the sacral regions and back­
wards along the tail. The sex skin was folded, reddened and oedematous. 
Histopathological examination of the mammary glands of this infant revealed 
slight ductal proliferation. Neither macroscopic nor morphological abnormal­
ities were encountered in any of the other infants. Organ weight analyses of 
the treated infants were comparable to those of the untreated control infants.
During the experimental period post partum menses were not recorded in 
any of the mothers. Following weaning and the removal of the infants, one of 
the control animals returned to cycle after 6 weeks, but neither of the dosed 
females returned to menses following withdrawal of ethinyl oestradiol for the 
12-week observation period.
DISCUSSION
The results of this study indicate that physiological change may occasional­
ly be induced in the infants of mothers dosed with ethinyl oestradiol, indicat­
ing that the oestrogen is secreted in the milk. However, tiie levels secreted 
were below the limits of detection of our assay methods.
The male rhesus monkey is bom  showing swelling and turgescence of the 
scrotum [7]. This naturally occurring physiological effect appears to be caused 
by a marked increase in circulating levels of oestradiol and oestrone during the 
last days of pregnancy in the rhesus monkey [2,6].
33
In the infant in which marked physiological change was induced there was 
no evidence of the proliferative changes normally associated with oestrogen 
administration.
The experiment shows that once lactation is established in the rhesus 
monkey the administration of ethinyl oestradiol at high dosage levels does not 
suppress lactation. There was slight body weight loss in the mothers and 
marginal suppression of body weight gain in the suckling infants of the two 
treated dams.
The administration of ethinyl oestradiol to the non-lactating rhesus monkey 
has been associated with elevation of SAIT and LAP values [4]. However, no 
changes in these liver enzymes were recorded over the experimental period.
The results indicate that in the rhesus monkey the administration of daily 
doses of ethinyl oestradiol had little effect on lactating rhesus monkeys and 
their suckling infants. The extrapolation of experimental data to man is notor­
iously difficult, but this subhuman primate model suggests that the transfer 
of ethinyl oestradiol at the low dosage levels given in “the pill” does not 
constitute a major health hazard.
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SUMMARY
Diethylstilboestrol (DES) was administered parenterally to a group of four 
pregnant rhesus monkeys at the dose level of 1 mg/kg/day from day 45 of 
gestation until parturition. Two monkeys aborted, but two infant monkeys, 
one male and one female, were bom. The infants were killed after an 84-week 
observation period. At post-mortem examination the prostate and seminal 
vesicles of the male infant were found to be small. The reproductive tract of 
the female infant was normal.
INTRODUCTION
The experimental administration of androgens to pregnant rhesus monkeys 
at an appropriate stage of gestation — that is, from approximately the 40th to 
90th days of gestation — has been shown to transform female foetuses into 
female pseudohermaphrodites [10,12—14]. Apart from the report from 
Morris and van Wagenen [5], who administered oestradiol and DES to 
pregnant rhesus monkeys, there appears to be no other published account of 
the administration of oestrogens to pregnant simian primates.
MATERIALS AND METHODS
Four wild-caught female rhesus monkeys (Macaca m ulatta) were housed 
separately in metal cages. Clinical observations were made daily to determine 
the stage of the menstrual cycle of each animal. During the 10th, 11th and 
12th days of the menstrual cycle (first day of menses being day 0 of the 
menstrual cycle and the 11th day of the menstrual cycle being day 0 of gesta­
tion), each female was housed with a mature male rhesus monkey of proved 
fertility to allow mating to take place [11]. Pregnancy was confirmed by
Abbreviations: AsT, aspartate aminotransferase; DES, diethylstilboestrol.
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rectal palpation of the uterus. Food intake was monitored daily and body 
weight recorded at weekly intervals. DES was administered daily by intra­
muscular injection at a dose level of 1 mg/kg from the 45th day of gestation 
until parturition, which in the rhesus monkey occurs at approximately the 
168th day of gestation.
The infant rhesus monkeys were then maintained for a period of 84 weeks. 
Clinical observations were made daily and body weight recorded every 4 weeks. 
When the infants weighed 1 kg (after 20 weeks) they were weaned. 
Subsequently, food consumption was monitored daily and body weight 
recorded at weekly intervals. Routine haematological and biochemical 
laboratory investigations were performed just before the animals were killed.
At the end of the 84-week observation period, the infant rhesus monkeys 
were killed and immediately afterwards a full macroscopic post-mortem 
examination was performed, during which particular attention was paid to the 




Beginning at the 45th day of gestation, DES was injected intramuscularly at 
the dosage rate of 1 mg/kg until termination. Two of the pregnant females, 459 
and 509 aborted after 31 and 87 days of treatment, respectively. The pregnant 
female 177 9 gave birth to  a male infant on the 168th day of gestation, after 
receiving a total of 655 mg of DES. The pregnant female 1859 gave birth to a 
female infant on the 169th day of gestation, after receiving a total of 642 mg 
of DES. The average gestation period of untreated control rhesus monkeys 
maintained at the Huntingdon Research Centre is 166.8 days with a range of 
156—177 days [3]. Food consumption and body weight of monkeys 1779 and 
185 9 were not adversely affected.
In fa n t data
Both infants weighed 425 g at birth. The mean birth weight of rhesus 
monkeys maintained at the Huntingdon Research Centre is 440 ± 50 g [3].
The infant monkeys were maintained for an observation period of 84 weeks.
At birth, both infant monkeys showed slight folding and reddening of the sex 
skin. These changes persisted for 12 weeks in the male infant of monkey 177 9 
and for 10 weeks in the female infant of monkey 1859. Both infants were 
weaned at approx. 20 weeks of age when they weighed 1 kg. The body weight 
gain during the first year, while fluctuating, was similar to that normedly en­
countered in untreated control animals at the Huntingdon Research Centre.
With the exception of a slightly lower total serum protein level in the infant 
of monkey 177 9 and a slightly raised serum AsT level in the infant of monkey 
1859, the results of the preterminal laboratory investigations were within the 
normal range.
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At post-mortem examination the male infant of monkey 177 9 weighed 
1.75 kg and the female infant of monkey 1859 weighed 2.20 kg. With the ex­
ception of the testes of the male infant, which were found in the inguinal 
region, the external genitalia were normal in appearance. Internally, both the 
prostate and seminal vesicles were found to be poorly developed. The right 
and left seminal vesicles weighed only 0.148 g and 0.188 g respectively. The 
prostate was located by examination of the prostatic urethra for the openings 
of the prostatic ducts and weighed 0.128 g. The combined prostate and 
seminal vesicle weight for animals weighing 1.71 kg ± 121 g (mean of 6) is 
normally 0.90 ± 0.14 g. In the female infant, the only abnormalities seen on 
macroscopic examination were prominent folds in the vaginal mucosa. The 
remaining relative and absolute organ weights were considered to be within 
the normal range for animals in this age group.
At histological examination the testes of the male infant were found to be 
immature, with spermatogenesis proceeding to the spermatocyte stage only.
No morphological abnormalities were found in the prostate and seminal 
vesicles, the appearance of which was essentially similar to that encountered in 
immature male rhesus monkeys of this age. The reproductive tract of the 
female infant was normal. Only small secondary follicles were evident in the 
ovaries and shallow endometrial glands were noted in the uterus. The cervix 
and vagina were lined by well developed columnar and stratified squamous 
epithelia respectively. No other morphological changes were seen that could be 
attributable to treatment with DES.
DISCUSSION
The results indicate that prenatal exposure to DES partially inhibits the 
normal development of the male accessory sex glands of rhesus monkeys. 
Further evaluation with larger groups of monkeys is necessary to confirm 
these preliminary investigations. Morris and van Wagenen [5] reported that no 
foetal abnormalities were observed when DES was administered to 14 pregnant 
macaques. The dosage rate and dosing period varied considerably, precluding 
valid comparison. In addition, a postnatal recovery period was not allowed. 
Abnormalities of the male reproductive tract have been reported in rats [2], 
hamsters [7] and mice [4, 6] following prenatal administration of DES.
Maternal plasma levels of steroidal oestrogens increase progressively during 
pregnancy, particularly during the last 7 days [1] and are thought to  be 
placental in origin. The steroid concentration of oestradiol in maternal plasma 
is higher than in the amniotic fluid, although this relationship is reversed for 
oestrone, especially during the 20 days preceding delivery. Such changes are 
undoubtedly responsible for the swelling and turgescence of the scrotum seen 
at birth in male rhesus monkeys [15]. In this experiment, DES had a marked 
effect on the sex skin of both infants, suggesting that the foetuses were ex­
posed to high concentrations of DES.
Our results have not ruled out the possibility that DES in the rhesus monkey 
is embryotoxic, causing early embryonic death and abortion.
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Histological examination of the vaginal and cervical mucosa in the female 
infant was unrewarding. In women exposed to DES in utero, non-neoplastic 
changes included cervical erosion and vaginal adenosis, the incidence of which 
is about 30% in the whole population exposed to DES [8, 9]. We do not yet 
know whether similar non-neoplastic changes could be induced in female 
rhesus monkeys.
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